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Exploring the functional constraints on bacterial 
essential gene expression with CRISPRi 
John Sumblin Hawkins 
Abstract 
Essential genes are critical for cell viability. In bacterial cells these genes are unusually 
connected across their genetic network, frequently direct targets of antibiotics, and 
disproportionately expressed to the transcriptome and proteome. Despite their centrality 
to bacterial biology, essential genes have been poorly studied in vivo for want of the 
facile and high-throughput methods needed to systematically compromise activity 
essential genes while still maintaining the population levels necessary for 
measurements and assays of their functional impact. We applied CRISPR interference 
(CRISPRi) to create knockdowns of every essential gene in Bacillus subtilis, then 
assayed those knockdowns using chemical genomics, high-throughput microscopy, and 
growth experiments, which collectively provided significant insights into the organization 
and functional relevance of the bacterial essentialome. With this work as a springboard 
we developed a modified CRISPRi system leveraging the predictable reduction in 
efficacy of imperfectly matched sgRNAs to generate specific levels of CRISPRi activity 
and demonstrate its broad applicability in bacteria. Using libraries of such mismatched 
sgRNAs, we characterized the expression fitness relationships of essential genes in 
Escherichia coli and Bacillus subtilis. These organisms, though separated by ~2 billion 
years of evolution, conserve not only the essential genes themselves but in the majority 
of cases the relationships connecting their individual expression to overall fitness, 
suggesting that the tradeoffs underlying bacterial homeostasis are deeply fundamental.  
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Chapter 1 
Introduction 
As recently as fifteen years ago few people would have recognized the acronym 
CRISPR, even within the field of Biology. Francisco Mojica(Mojica et al. 2005), Christine 
Pourcel(Pourcel, Salvignol, and Vergnaud 2005), and Alexander Bolotin(Bolotin et al. 
2005), working independently, realized in 2005 that the pattern of Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPR) that they had been studying in 
bacterial genomes was connected to phage genomes, and correctly hypothesized that 
this might be a keystone of adaptive immune systems in bacteria. A year later, this 
hypothesis was elaborated by Eugene Koonin(Makarova et al. 2006). The chain of 
events which followed call to mind the rolling boulder chasing Indiana Jones through the 
prologue in "Raiders of the Lost Ark". 
In an effort to arm themselves against cripplingly expensive outbreaks of phage 
infection in yoghurt production vats, researchers at Danisco France tested and 
confirmed this adaptive immune system hypothesis in 2007(Barrangou et al. 2007). 
They additionally identified the now-famous CRISPR-associated protein Cas9 as 
sufficient, in partnership with the CRISPR spacers, to effect genetic 
interference(Sapranauskas et al. 2011). Marraffini and Sontheimer(Marraffini and 
Sontheimer 2008) demonstrated the following year that, unlike RNAi silencing 
mechanisms, these effectors were targeting DNA. By 2012, researchers on both coasts 
of the United States and in Europe had taken the powerful promise of this simple 
system from abstract concept to practical laboratory tool(Barrangou 2012; Jinek et al. 
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2012; Zhang 2012). The web of use cases grew explosively from there, including 
functional genomics via genome-scale knockout screens in human cells(Tim Wang et 
al. 2014; Zhou et al. 2014), improved construction of mouse cancer models(Choi and 
Meyerson 2014; Chen et al. 2014; Torres et al. 2014), correction of disease-causing 
genetic mutations(Wu et al. 2013; Schwank et al. 2013), and acceleration of research 
on agricultural organisms such as rice and wheat(Jiang et al. 2013). 
Cutting DNA at precisely controlled locations to inactivate or alter a gene remains an 
exciting and central part of the tree of tools rising from this fertile seed. But that second 
phrase, "precisely targeted locations", has deep implications. CRISPR/Cas affords the 
ability to target virtually any protein effector of interest to those same precisely 
controlled DNA locations. Jinek et. al.(Jinek et al. 2012; Gasiunas et al. 2012) and 
Gasiunas et. al.(Jinek et al. 2012; Gasiunas et al. 2012) showed that Cas9 could be 
used to cut DNA in vitro, and that this capability was tied to two domains -- a RuvC 
domain and an HNH domain, with each of the two cutting one strand of the target locus. 
However, these domains could be mutationally inactivated without impeding Cas9's 
RNA-targeted binding of DNA. Simply substitute in the catalytically inactive protein 
dCas9, directly or indirectly tethered to a transcriptional regulator, fluorophore, or any 
other effector domain, and "program" the partnered 20-base guide to point to a DNA 
target of interest. Your effector and DNA target will efficiently and robustly be held in 
close proximity by the dCas9. 
In 2013, Stanley Qi demonstrated(Qi et al. 2013) the elegant potential of this idea's 
simplest possible implementation by fusing dCas9 to: absolutely nothing. Even though 
catalytically inactivated dCas9 no longer "does" anything beyond finding its target, the 
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tenacity with which it holds on to said target is sufficient to disrupt transcriptional 
expression of RNA molecules from the targeted locus. Dubbed "CRISPR interference", 
or simply "CRISPRi", this idea has since been successfully applied in both 
eukaryotes(Larson et al. 2013; Gilbert et al. 2013) and prokaryotes(Peters et al. 2016, 
2019). In eukaryotes CRISPRi is a bit more complicated, generally depending on a 
fused effector domain such as KRAB to exact the desired degree of control over 
expression levels.  The simplicity of CRISPRi is therefore especially attractive and 
exciting in the domain from which CRISPR was originally drawn: Bacteria. 
When I joined UCSF as a graduate student, I was very excited to study the genetic 
networks underpinning the rich and complex life of bacterial cells. I was also, having 
been fortunate enough to spend the prior year volunteering with Jonathan Weissman's 
lab, deeply impressed by the power of genome-scale techniques like ribosome 
profiling(Ingolia et al. 2012) and NET-seq(Churchman and Weissman 2012). 
Opportunity to pursue both aims arose from a budding collaboration between Stanley Qi 
and Carol Gross. I joined both labs, and began working to develop CRISPRi 
technologies for high-throughput functional genomics in bacteria. When Stanley later left 
for Stanford, I remained at UCSF with the Gross lab. But Stanley's influence had been 
impactful, and this project had legs. 
From the beginning of my thesis work I was excited about the power these new 
techniques could offer researchers exploring bacterial biology, yet frustrated to think 
how out-of-reach these new techniques might seem for labs not sitting scant dozens of 
feet from UCSF's Center for Advanced Technology, nor from the aforementioned labs at 
the vanguard of CRISPRi development. I wanted to expand the CRISPRi toolset, with a 
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particular eye towards the democratization of CRISPRi technology. I want other labs to 
benefit from powerful CRISPRi tools without expensive overhead and multi-year 
learning curves. 
I started by developing a software pipeline to identify usable targets for sgRNA design. 
My publicly available suite of Python scripts automates the process of identifying all 
possible guide targets in a genome, and estimates the dangers of any off-target 
matches for said targets. It also annotates guides with important information about their 
position relative to interesting genomic features, particularly any overlap with the coding 
sequence of specific genes. 
We soon found an important use for this technology. Complete (i.e. uncomplemented) 
removal of essential genes makes further study of an organism largely impossible -- it 
no longer grows(Koo et al. 2017). This feature made it very difficult to probe the precise 
functional relevance of essential genes in bacteria, and existing technologies such as 
introducing degradation tags(Cameron and Collins 2014) or targeting them with 
sRNAs(Storz, Vogel, and Wassarman 2011) are both labor intensive and imprecise. Yet 
essential genes -- often important targets of antibiotics and other chemicals, heavily 
enriched for genetic interactions with other genes, and certain to directly impact fitness 
in the neutral laboratory setting -- are critically important for understanding the overall 
genetic networks of bacteria.  We used the guides designed by this pipeline to knock 
down essential genes in B. subtilis in order to examine their functions and network 
topology. (Chapter 1 -- Peters, et. al.) 
Recently, our collaborators suggested(Gilbert et al. 2014) that insights gleaned from 
clarifying the off-target effects of an sgRNA/Cas9 pair could be used to modulate guide 
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efficacy. I ran with this idea. By introducing mismatches into the guide relative to the 
primary target, I might be able to reduce the frequency of on-target events, thereby 
creating guides that would impart some reduced level of knockdown in the presence of 
saturating dCas9 expression. Building a library of such mismatched guides could then 
provide a range of knockdowns for any targeted gene.  It struck me that such a range of 
knockdowns presented a major opportunity.  Having a range of phenotypes for each 
gene would make it much more likely that a given experiment would capture the 
phenotypic "sweet spot" in which a gene was depleted enough to impair fitness, but not 
so depleted as to exceed our limits of fitness detection or to occlude the interaction of 
that impairment with other sources of stress.  This would hold true for any gene 
rendered contextually critical by a secondary stress such as a chemical antagonist or 
missing nutrient, but it was especially true for constitutively essential genes.  Studies in 
yeast(Li et al. 2011) indicated that essential genes were interaction hubs for networks, 
highlighting the importance of including them in our analyses. 
I realized that building and evaluating the mismatched guide library on the essential 
genes of B. subtilis was a major project on its own, and this became the cornerstone of 
my thesis. This work, reported in Chapter 2, expanded to include an analysis of a 
comprehensive knockdown library of gfp, as well as an analysis of a mismatched guide 
library targeted to the E. coli essential genes. We were able to develop a predictive 
model for mismatch knockdown efficacy from the GFP library and used that to 
characterize knockdown – fitness relationships of each essential gene in E. coli and B. 
subtilis. Additional aspects of the work are reported in several appendices. As the lab 
had never before performed large scale growth experiments, I validated the growth 
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defects of mismatched guides inferred from pooled growth with individual growth 
experiments (Appendix 1). We took a great deal of care in considering the diversity of 
representation within a pooled experiment, evaluating the importance of various 
bottlenecks and other sources of non-uniformity and noise in the constructed libraries of 
strains as well as the implications regarding the reproducibility and resolution of the 
fitness measurements for those strains (Appendix 2). I also used the library to explore 
how variably knocked down dfrA responds to low doses of Trimethoprim, to explore the 
idea that this method might refine our quantitative understanding of drug-target 
interactions. (Appendix 3). I developed small libraries of 10 guides per gene, to 
demonstrate the practical versatility of this approach (Appendix 4).  Our original libraries 
included “double-mismatch” guides -- guides with a second mismatch.  Single mismatch 
guides prove sufficient to our ends, but we show that our predictive model largely 
extends to the double-mismatch guides. (Appendix 5).  In addition to the sgRNA design 
code discussed above (Appendix 6), I have provided software tools for the design of 
mismatch guide libraries and the analysis of pooled growth experiments on strains 
containing those guides (Appendix 7). 
Before this thesis project, CRISPRi was a new idea, readily accessible for only the most 
fortunate of bacterial research labs. It is my sincere hope that the resources and 
analyses described in this thesis will allow other investigators to easily adapt these 
methods for their organism of choice, as well as to use the libraries described herein to 
examine conditions beyond the narrow set explored by this work. 
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Chapter 2 
 
A Comprehensive, CRISPR-based Functional Analysis of 
Essential Genes in Bacteria 
 
SUMMARY 
Essential gene products underpin the core reactions required for cell viability, but their 
contributions and relationships are poorly studied in vivo. Using CRISPR interference, we 
created knockdowns of every essential gene in Bacillus subtilis and probed their phenotypes. 
Our high-confidence essential gene network, established using chemical genomics, showed 
extensive interconnections among distantly related processes and identified modes of action for 
uncharacterized antibiotics. Importantly, mild knockdown of essential gene functions 
significantly reduced stationary phase survival without affecting maximal growth rate, suggesting 
that essential protein levels are set to maximize outgrowth from stationary phase. Finally, high-
throughput microscopy indicated that cell morphology is relatively insensitive to mild knockdown 
but profoundly affected by depletion of gene function, revealing intimate connections between 
cell growth and shape. Our results provide a framework for systemati c investigation of essential 
gene functions in vivo that is broadly applicable to diverse microorganisms and amenable to 
comparative analysis. 
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INTRODUCTION 
Essential gene functions underpin core cellular processes. Interrogating the relationships 
among essential gene functions is critical for understanding how bacterial growth is controlled 
and for facilitating drug development. Yet, few approaches can assess essential gene function 
in vivo to elucidate their connections. Neither gene-deletion libraries (Baba et al. 2006; Winzeler 
et al. 1999) nor saturating transposon mutagenesis (Goodman et al. 2009; van Opijnen, Bodi, 
and Camilli 2009) can be used to study essential genes, as cells cannot survive without their 
functions (Christen et al. 2011). Several high-throughput approaches have been used to identify 
or perturb essential genes in eukaryotes, including destabilizing the 3’ UTR of mRNAs (DaMP 
alleles)(Breslow et al. 2008), CRISPR (clustered regularly interspaced short palindromic 
repeats)/Cas9 gene editing (Blomen et al. 2015; Tim Wang et al. 2015), and CRISPR/dCas9 
transcriptional regulation technologies (Gilbert et al. 2014). The only study screening essential 
genes in bacteria used antisense RNA knockdowns to screen for antibiotic sensitivities (H. H. 
Xu et al. 2010), a method of limited utility due to variable efficacy (Forsyth et al. 2002). 
Here we establish a CRISPR interference (CRISPRi) framework for systematic phenotypic 
analysis of essential genes in bacteria. CRISPRi uses a nuclease-deactivated variant of 
Streptococcus pyogenes Cas9 (dCas9) paired with a single guide RNA (sgRNA) to sterically 
hinder transcription at the sgRNA-base pairing genomic locus (Qi et al. 2013) and is a specific 
and efficient approach for knockdown, with demonstrated applicability in bacteria. We generated 
a comprehensive essential gene-knockdown library in the Gram-positive model bacterium 
Bacillus subtilis and used the library to enable drug target discovery, establish a functional 
network of essential gene processes, characterize how cell morphology and growth rate 
respond to reductions in essential gene expression, and dissect essentiality in a highly 
redundant genetic pathway. Our study provides a framework for comprehensive, high-
throughput analysis of essential gene functions applicable to diverse bacteria.  
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RESULTS 
CRISPRi is effective, specific, and titratable in B. subtilis 
We established a CRISPRi system in B. subtilis, consisting of S. pyogenes dcas9 driven by a 
xylose-inducible promoter (Pxyl) and sgRNAs expressed from a strong, constitutive promoter 
(Pveg), both transferred to the chromosome via integrating plasmids (Figure 2.1 A). This system 
is very efficient, exhibiting 3-fold repression of red fluorescent protein (RFP) without induction 
and 150-fold repression with full dcas9 induction (Figure 2.1 B, 2.8 A). Although we also report 
a system with no basal repression based on a weak IPTG-inducible promoter (Figure 2.8 B), 
we used Pxyl exclusively throughout to consistently sensitize the library with slight knockdown 
and avoid inconsistencies resulting from slight variations in IPTG induction.  
Our Pxyl-based CRISPRi system is titratable, with unimodal rfp repression at the single-cell level 
across sub-saturating inducer concentrations (Figure 2.1 B, 2.8 C), and high specificity, 
repressing only rfp expression at saturating inducer concentrations (Figure 2.1 C). We used 
NET-seq to identify the genomic positions of transcribing RNA polymerase (Larson et al. 2014), 
showing that CRISPRi sterically blocks transcription in B. subtilis (Figure 2.1 D, 2.8 D), as in 
Escherichia coli (Qi et al. 2013). CRISPRi is polar (Peters et al. 2015), with all downstream 
genes in an operon showing equivalent knockdown (Figure 2.1 E), and also reduces expression 
of upstream genes in the operon (Figure 2.8 E). Thus, CRISPRi technology is suitable for 
examining gene function at the operon level. 
A CRISPRi knockdown library of essential genes 
We constructed an arrayed library of B. subtilis strains expressing computationally optimized 
sgRNAs (Extended Experimental Procedures) targeting the 289 known or proposed essential 
genes (Table 2.1). The sgRNAs targeted unique DNA sequences at the 5´ ends of genes, 
where CRISPRi is most effective (Qi et al. 2013). Nearly all sgRNAs (~94%) targeting bona fide 
essential genes (258 genes total, Extended Experimental Procedures) (Koo et al. 2017) 
decreased colony size on agar plates with xylose (≥25% reduction in area compared to the 
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control; Table 2.1; Extended Experimental Procedures). Control cells expressing only dcas9, or 
dcas9 and an sgRNA targeting an innocuous gene (rfp), had no growth defects (Figure 2.8 F). 
We conclude that a single sgRNA is sufficient for effective knockdown of essential genes, 
simplifying CRISPRi library design in bacteria. 
CRISPRi-based essential gene phenotyping and drug target discovery 
The ~3-fold repression of our knockdown library without induction (basal repression; Figure 2.1 
B, 2.8 A) sensitized strains to various chemicals. This enabled us to define essential gene 
phenotypes via chemical-genomic analysis by measuring colony size against 35 unique 
compounds (Extended Experimental Procedures).  We achieved high reproducibility, as 
measured by correlated colony sizes (R = 0.89, Figure 2.9 A). We converted colony sizes to 
chemical-gene scores (Figure 2.9 A-D; Table 2.2) (Nichols et al. 2011), and identified 
significant chemical-gene phenotypes (false discovery rate ≤5%) (Nichols et al. 2011). Most 
knockdowns of antibiotic targets were hypersensitized to their cognate drug (e.g. dfrA/folate 
biosynthesis to trimethoprim (Myoda et al. 1984), fabF/fatty acid metabolism to cerulenin 
(Moche et al. 1999); Table 2.2). Although fabI, the target of triclosan (Schujman et al. 2001), is 
not essential due to a gene duplication (Thomaides et al. 2007), another knockdown in the 
pathway (fabG) was sensitized (Table 2.2). We conclude that our CRISPRi platform effectively 
identifies known drug-gene interactions. 
We tested our essential knockdown library as a platform for drug target discovery by screening 
against MAC-0170636, an antibiotic that upregulates the cell wall-damage responsive promoter 
PywaC (Czarny et al. 2014) by an unknown mechanism. Undecaprenyl pyrophosphate synthetase 
(uppS) was the most sensitized knockdown (Figure 2.2 A; Table 2.2), and we confirmed its 
sensitivity in liquid (Figure 2.2 B). Conversely, uppS overexpression increased MAC-0170636 
resistance relative to wild-type (WT) cells (Figure 2.2 B). Purified B. subtilis UppS activity was 
inhibited by MAC-0170636 with an IC50 of 0.79 μM (Figure 2.2 C), indicating that UppS is the 
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direct target of MAC-0170636. UppS purified from another Firmicute, Staphylococcus aureus, 
was completely resistant to MAC-017063 (Figure 2.9 E), as was S. aureus itself. Likewise, B. 
subtilis expressing only S. aureus uppS was resistant (Figure 2.2 D). These results highlight the 
utility of our knockdown library for identifying direct targets of uncharacterized compounds; 
CRISPRi portability suggests its utility in future organism-specific drug-discovery efforts. 
 
Functional analysis of the essential gene network 
Highly correlated responses of gene knockdowns across chemical conditions (phenotypic 
signatures) indicate functional connections (Nichols et al. 2011). We established a network of 
gene-gene connections using statistically significant correlations among the phenotypic 
signatures of our essential gene knockdowns, based on both direct or indirect effects of drug-
gene interactions (Figure 2.3 A, 2.9 B-D, 2.10; Table 2.3; Extended Experimental Procedures). 
The network was rich in known biological connections among genes in related processes such 
as cell-wall biosynthesis and cell division (Figure 2.3 B). 
We quantitatively validated the network with a ROC curve. Because CRISPRi exhibits polarity, 
this analysis was based on operons containing essential genes (“essential operons”, n = 203), 
rather than on the individual genes themselves (Extended Experimental Procedures, Table 2.3). 
We compared high-confidence gene-gene connections in the STRING database (http://string-
db.org/) (Szklarczyk et al. 2015) with correlations between essential operons in our chemical-
genomics dataset that met our correlation threshold (R=0.572; Figure 2.3 C; Extended 
Experimental Procedures). Our network showed excellent agreement with STRING, with a ~20-
fold ratio of true to false positive rates (Figure 2.3 C, inset). 
We investigated the relationship between network connections and gene function by assigning 
essential operons to functional groups using the SubtiWiki online resource (http://subtiwiki.uni-
goettingen.de/) (Michna et al. 2014). Of the 61 non-overlapping functional groups, the 35 with 
two or more essential operons were assessed for connectivity within the group (intra-
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connectivity). Mean intra-connectivity was ~2.4, compared with a background mean connectivity 
of ~0.3 (p < 10-5), with 10 groups showing connectivity among ≥3 essential operons (Table 2.3). 
Indeed, the ROC analysis showed strong specificity and sensitivity for recapitulating existing 
intra-process connections in STRING (Figure 2.11 A), with excellent recovery of connections 
within functional groups (Figure 2.11 B). Connections within the peptidoglycan (PG) cell wall 
biosynthesis (18) and DNA replication (9) functional groups were most dense, likely reflecting 
convergence of PG precursor biosynthesis and localized cell wall assembly (Turner, Vollmer, 
and Foster 2014) and replisome protein-protein interactions (Sanders, Dallmann, and McHenry 
2010), respectively. 
We next compared connectivity between functional groups (inter-connectivity) in our network 
with those in STRING, finding common connections and important distinctions (Figure 2.10 D, 
2.10 E). First, the balance of intra- and inter-process connections differed; 46.2% of connections 
in STRING were inter-process, versus 59.0% in our network (p < 10-4). Second, STRING inter-
process connections were biased toward extensively studied processes, e.g. 39% of STRING 
but only 4.3% of our inter-process connections were between ribosomal proteins and translation 
factors. Moreover, 84% (113/134) of connections unique to our network were between 
processes (Table 2.3), highlighting the ability of our open-ended approach to detect such 
connections. Finally, our network revealed many connections between operons in distant 
functional groups. Using the hierarchical annotation levels from SubtiWiki (Michna et al. 2014) 
as an approximation of “annotation distance”, we found that novel connections in our network 
were skewed toward processes furthest apart in annotation, whereas those in STRING were 
predominantly between related processes (Figure 2.3 D). Some distant connections were 
intuitive, such as DNA replication (holB) and folate biosynthesis (folC and the sul-folB-folK 
operon), likely reflecting the folate requirement for dTTP production (Hardy et al. 1987). Other 
connections were unexpected, such as those between peptidoglycan (PG) biosynthesis/cell 
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division and DNA replication/modification (e.g., ftsL and dnaX, murC and gyrB, ddl-murF and 
ydiO); these connections may be involved in failsafe mechanisms that link division and DNA 
replication (Arjes et al. 2014). 
We explored the unexpected connection between transcription (rpoB) and cell division (ftsL), 
which is based on shared sensitivities to DNA intercalators and cell-wall antibiotics (Figure 2.9 
D). Using RNAseq, we found that basal knockdown of rpoB reduced the rpoB-rpoC mRNA level 
by two-fold. Among the few other substantial expression changes (Figure 2.11 D), we found 
several down-regulated envelope genes including manA (4-fold), which is involved in cell-wall 
integrity (Elbaz and Ben-Yehuda 2010), and sigW (1.5-fold to 2-fold), a master regulator of 
envelope stress (Cao et al. 2002) (Table 2.3). Selective reduction of several envelope functions 
due to rpoB knockdown could result in cell-wall defects that mimic those caused by knockdown 
of late-acting cell-division genes. 
We also identified novel connections to essential genes of unknown function (Figure 2.3 A, 
2.10, 2.11 E). For example, resistance to cell wall-targeting antibiotics drove strong correlations 
among the largely uncharacterized gene ylaN (Figure 2.9 F) (Hunt et al. 2006; L. Xu et al. 
2007), iron-sulfur cluster biogenesis, and isoprenoid biosynthesis, the latter of which depends 
on the iron-sulfur cluster enzyme IspH (Gräwert et al. 2004; Wolff et al. 2003). These results 
suggest that defects in cellular iron homeostasis underlie the connections to ylaN. Indeed, in 
follow up experiments, we determined that ylaN is non-essential with added iron(III) (Figure 
2.11 F), further highlighting the ability of our unbiased approach to identify novel connections 
among essential processes. 
 
Growth characteristics of the essential gene knockdown library 
We measured apparent lag, maximum growth rate, and saturating density of growth curves for 
all basal knockdowns in LB medium (Figure 2.4 A-B; Extended Experimental Procedures). 
Almost all knockdowns (~80%) had a maximal growth rate equivalent to the control (Figure 2.4 
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B and inset); ribosomal proteins were the only functional category with slower growth rates 
relative to other knockdowns (p = 0.0008, t-test). However, most knockdowns (95%) had longer 
apparent lag times (Figure 2.4 A, inset), and cell wall-synthesis genes were enriched for the 
longest lags (p = 0.0013, Mann–Whitney U test, Table 2.4). CRISPRi repression was 
maintained in stationary phase (Figure 2.11 G). 
We determined whether longer apparent lag times reflected strain-specific differences or 
decreased viability. Both the fraction of growing cells on agarose pads (Figure 4C) and plate 
viability measurements (Figure 2.4 D) of strains spanning the apparent lag times negatively 
correlated with apparent lag. Apparent lag times also tracked with expectations from the number 
of live cells present. For example, using the 45-min doubling time in batch culture (2.4 B inset), 
the ~8-fold reduction in mraY knockdown viable cells (Figure 2.4 C-D) requires ~3 additional 
divisions, accounting for the 2.1-h increase in apparent lag. Moreover, viable mraY knockdown 
cells and the control had equivalent growth rates after transfer to an agarose pad with fresh LB 
(Figure 2.4 C, inset). Together, these surprising results suggest that slight reductions in 
essential gene products affect outgrowth from stationary phase, creating a mixed population in 
which some cells exhibit WT outgrowth and others are either dead or non-growing. 
 
Basal knockdown of essential genes results in changes in cellular dimensions 
that reveal shape actuators and modulators 
Our library offers an unprecedented opportunity to examine whether basal knockdown of 
essential genes affects cell morphology. To provide baseline values, we quantified the 
dimensions of WT cells. Cells were imaged 3.5 h after different degrees of dilution into fresh 
medium (Extended Experimental Procedures), and therefore had different culture optical 
densities (OD). We found that median cell length and width varied systematically with extent of 
dilution (Figure 2.5 A), likely reflecting growth phase differences as cells cycle through nutrients 
in rich medium (LB). Cells diluted less were smaller, reflecting their slower growth rate at the 
time of imaging, similar to previous reports linking cell size and steady-state growth rate 
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(Schaechter, Maaloe, and Kjeldgaard 1958) and consistent with known shortening in stationary 
phase (Overkamp et al. 2015). 
We next determined morphological parameters of the essential gene basal knockdowns to 
pinpoint proteins for which a small expression change results in altered shape, using high-
throughput imaging at 3.5 h after dilution (Extended Experimental Methods). Because of 
variable stationary-phase outgrowth (Figure 2.4 C-D), culture OD varied widely at the time of 
imaging. We found a general relationship between growth rate and OD for virtually all 
knockdowns (Figure 2.11 H), indicating a large range of instantaneous growth rates at imaging. 
Nonetheless, the length and width of the knockdowns were highly correlated (Figure 2.12 B), 
similar to WT cells across dilutions (Figure 2.12 A). The fact that cells reach their maximum 
growth rate at a fixed OD (Figure 2.11 H), rather than at a fixed number of doublings after 
growth resumption, underscores the importance of cell density and the extracellular milieu in 
growth rate control. 
Basal knockdowns that deviated from the length/width trendline (Figure 2.5 B; Table 2.5) could 
represent proteins involved in either actuating or regulating growth of the shape-determining cell 
wall. Only cell-envelope genes exhibited significant enrichment of outliers (average median 
length deviation = 0.99 µm, p < 0.0005 by bootstrapping, Extended Experimental Procedures; 
Figure 2.5 B), as expected because they are largely PG synthesis-related and are therefore 
actuators of cell shape. To validate our identification of outliers and ensure that cell chaining 
was rare, we used the membrane stain, FM4-64, on a subset of strains with different median 
cell lengths, finding that length measurements from phase images and peripheral fluorescence 
were highly correlated (Figure 2.12 A).  
Several outliers in other functional groups were intriguing, as they could identify cell shape 
regulators. Basal knockdown of tufA, encoding the translation elongation factor Tu, resulted in 
cells that were substantially shorter than expected (Figure 2.5 B, Table 2.5); Tu interacts with 
the bacterial cytoskeleton protein and rod-shape determinant MreB (Defeu Soufo et al. 2010). 
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Knockdowns of several DNA replication genes (dnaX, dnaA, nrdE/F) resulted in longer cells 
(Figure 2.5 B, Table 2.5). Moreover, dnaX and ftsL, both of which are large mophological 
outliers, were also significantly correlated in our chemical screen, suggesting a functional 
connection between replication and division corroborated by multiple independent data types. 
As cell size is dependent on the degree of dilution prior to regrowth (Figure 2.5 A), direct 
comparisons of cellular dimensions among different strains require cells to be at the same OD. 
Large variation in lag times prevented us from measuring the entire library by this method. 
Instead, we examined two actin homologs (mreB and mbl) involved in coordinating PG 
synthesis (Scheffers and Pinho 2005) and the mur genes responsible for PG precursor 
synthesis at OD 0.3±0.05. Both actin homologs were wider than WT on average, with mreB 
exhibiting larger standard deviation, suggesting that cell width is particularly sensitive to MreB 
levels (Figure 2.5 C). The median cell lengths of mur strains were similar to WT (Figure 2.5 D), 
but widths (population median between 1.04-1.14 µm) were larger than no-sgRNA cells (1.02 
µm), validating their classification as outliers (Figure 2.5 D). The murB cell width increased 
monotonically with dcas9 induction (Figure 2.5 E), indicating that cell width is responsive to the 
cellular levels of PG precursors. 
In summary, our systematic screen for the essential gene products most intimately tied to cell 
shape identified genes with known ties to morphology (e.g. mreB/mbl) and cell wall synthesis, 
revealed a quantitative relationship between PG precursor gene expression and cell width, and 
uncovered potential new regulators of cell morphology. 
 
Single-cell characterization of terminal phenotypes provides a novel view of 
essential gene function 
We examined whether substantial depletion results in more extreme morphological changes 
than basal knockdown by imaging the entire library after prolonged (~24 h) induction of dcas9 
(“terminal phenotypes”; Extended Experimental Procedures). Remarkably, >60% of the strains 
(174/289, or 166/258 bona-fide essentials) exhibited morphological phenotypes, even excluding 
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strains with growth defects only (over-division or growth halting; Figure 2.6 Ai), a number far 
exceeding the 48 known cell envelope-related strains. Knockdowns displayed several 
predominant morphologies (Figure 2.6 Aii-viii, 2.12 B), whereas the control formed a uniform 
lawn of normal, rod-shaped cells (Figure 2.6 Aii). 
We quantified terminal morphologies by manually classifying phenotypes with an eight-
dimensional phenotype vector including lysis, bulging, uniform shape loss, bending, 
filamentation, over-division (shorter cells), and extent of growth. We assessed whether 
functionally related genes mapped to particular phenotypes. Many cell-envelope genes bulged 
(e.g. tagA/B/F/G/O (teichoic acid), mreC (cell shape/PG biosynthesis); Figure 2.6 Aiii), while 
many ribosomal genes displayed severe cell bending (Figure 2.6 Aiv). However, in some cases 
genes in different processes had similar terminal phenotypes, such as growth halting (Figure 
2.6 Avi) and bending (Figure 2.6 Aiv). Several metabolic genes (e.g. metK, dxs) exhibited 
bulging (Table 2.5), consistent with network connections between these processes and cell 
envelope synthesis/division (Figure 2.3 A). Finally, some strains displayed both bulging and 
lysis (Table 2.5), indicating that depletions in one process can lead to more than one terminal 
phenotype. 
Phenotypic variability within functional groups and common phenotypes of different groups 
made it challenging to map phenotype to process with simple visual comparison. Instead, we 
evaluated the similarities between terminal phenotype vectors for all SubtiWiki annotation pairs 
(Figure 2.6 B, Extended Experimental Procedures), a process conceptually similar to the one 
we used to identify inter-process connections in the chemical-genomics dataset. Our similarity 
matrix recapitulated known connections (e.g. PG synthesis/cell division) while providing support 
for novel network connections (e.g. fatty acid metabolism with both isoprenoid biosynthesis and 
several central-dogma annotations; Figure 2.6 B, 2.3 A, and 2.3 B). Terminal-phenotype links 
are consistent with and complement the high level of inter-process connectivity of the essential 
gene network (Figure 2.3 E). 
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Variable terminal phenotypes within a group might reflect the rate of gene-product depletion. We 
tested this hypothesis by inhibiting tRNA charging (Figure 2.6 C) either by valS (ValS 
aminoacyl-tRNA synthetase) knockdown, or by addition of serine hydroxymate, (tRNAser 
aminoacylation inhibitor). We observed dose-dependent phenotypes (Figure 2.6 C): shorter 
cells with slight depletion/inhibition (Figure 2.12 C-D), filamentation and bending with 
intermediate levels, and growth halting at high levels; these phenotypes were also exhibited by 
other aminoacyl-tRNA synthetase knockdowns (Figure 2.6 Aiv, vi, viii). Thus, the rate of 
inhibition of essential processes can qualitatively affect their terminal phenotypes.  
In summary, the majority of essential genes knockdowns display an altered terminal 
morphological phenotype. Phenotypes group both within and across functional processes, 
demonstrating the utility of morphology for revealing interactions, and can vary with the kinetics 
and extent of gene knockdown. 
 
Cellular behavior during the depletion of essential proteins 
To determine how rapidly terminal phenotypes are established, we performed timelapse 
imaging on nine representative knockdown strains in the presence of inducer. We placed 
exponentially growing cells on agarose pads of LB+xylose to initiate depletion, and imaged 
every 5 min to determine microcolony growth rates (Figure 2.6 D, 2.12 E). During the first 60 
min post-induction, WT cells maintained a constant elongation rate. The mbl knockdown 
maintained the WT growth rate, murD had a ~50% reduction, and the rest had a 20-30% 
reduction. Bulging (tagD) was the first prominent morphological phenotype observed (~40 min; 
1-2 cell doublings on agarose pads) with filamentation (pbpB), bending (accD), and lysis (murD) 
occurring after ~60 min (2-3 doublings; Figure 2.6 E). As depletion is primarily by dilution, these 
data indicate that reduction of at least 50-75% below basal knockdown is required to 
substantially affect growth rate and morphology. Many factors prevent precise quantification, 
including differential protein stabilities and polar effects on transcription. 
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We examined growth of the entire library during dcas9 induction by diluting stationary-phase 
cultures into liquid LB+xylose. Approximately 1/3 of the strains never emerged from stationary 
phase (OD600<0.06 at 7 h; Figure 2.13 A). These strains covered the entire range of lags, 
hence lack of growth could not be explained by the variable stationary-phase outgrowth 
exhibited under basal knockdown conditions (Figure 2.13 B). Instead, these strains identify the 
subset of essential proteins present in limiting amounts such that additional depletion beyond 
basal knockdown results in growth cessation or lysis (Table 2.4). 
Among strains that grew, we identified two distinct phenotypes (Figure 2.13 C, Table 2.4, 
Extended Experimental Procedures). Thirteen strains showed nearly linear growth; 9/13 
affected cofactor biosynthesis (e.g. heme biosynthesis) or electron transport (Figure 2.13 D), 
and may reflect cofactor availability. Fourteen strains enriched in either cell-envelope synthesis 
(5/14) or DNA replication (7/14) (Table 2.4) stalled after initial growth and then exhibited a 
marked decrease in OD, indicative of lysis (Figure 2.13 E). This common phenotype may reflect 
the close network and morphological connections observed between DNA replication and 
envelope synthesis (Figure 2.3 A). 
 
Dissecting a highly redundant gene network with multiplexed CRISPRi  
Genetic redundancy, prevalent in complex processes (e.g. construction of PG) (Meeske et al. 
2015) can mask the contributions of individual genes to essential processes. CRISPRi can 
simultaneously knockdown two genes (Qi et al. 2013); we show that CRISPRi can 
simultaneously knockdown eight unrelated, nonessential genes effectively (Figure 2.7 A and 
2.7 B). Using this multiplexing capability, we examined redundancy for the 16 penicillin binding 
protein (PBP)-encoding genes involved in PG synthesis. Simultaneous knockdown of pairwise 
pbp genes were viable at full dcas9 induction except pbpA/pbpH, a known synthetic lethal pair, 
and those including pbpB, the only essential PBP (Figure 2.7 C, 2.14 A-C; Table 2.6) (Wei et 
al. 2003). The observed fitness of double knockdowns was largely predicted by multiplying the 
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fitness of single mutants, a formalism developed for null mutations in parallel pathways (Figure 
2.14 A, Extended Experimental Procedures).  
We identified double knockdowns that were hypersensitive to PBP inhibitors (mecillinam, 
cefoxitin, and aztreonam; Figure 2.14 D-E), as these suggest possible triple synthetic gene 
combinations. Fitness of the pbpA/ponA/pbpD triple knockdown was lower than predicted 
(Figure 2.7 D) and we could not construct a ∆pbpA/∆pon∆/∆pbpD triple deletion, although we 
could introduce an innocuous deletion (∆trpC) or an unrelated pbp deletion (∆pbpC) into 
∆pbpA/∆ponA. Thus, the triple deletion is either extremely sick or synthetic lethal.  
PBP4 (pbpD), PBP2a (pbpA), and PBP1a/b (ponA) have transpeptidase activity and are septally 
localized (Scheffers, Jones, and Errington 2004). Reduced septal PG transpeptidation during 
cell division may underlie the severe growth defect of the triple knockdown. Control and single- 
and double-knockdown cells exhibited the expected rod-like shape, albeit with reduced cell 
length (Figure 2.7 E-F), potentially implicating these three genes in the regulation of cell 
division. By contrast, the triple mutant had distinct phenotypes including filamentation, cell lysis 
(Figure 2.7 E, white arrows), and bending along the cell contour (Figure 2.7 G, p<10-6), 
whether constructed with complete knockdown of all three genes or ponA knockdown in the 
∆pbpA/∆pbpD double. This phenotype is consistent with lethality caused by reduced septal 
transpeptidation, and showcases the ease of dissecting redundant pathways with CRISPRi.  
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DISCUSSION 
Bacteria typically have several hundred essential genes that encode the core reactions central 
to viability, together constituting ~10% of their total genetic complement. Lacking a facile way to 
reduce their expression, we had little understanding of in vivo relationships among essential 
gene processes, or how subtle imbalances in essential pathways impact cellular homeostasis. 
This work is a major advance in the study of bacterial essential genes, providing a systematic, 
unbiased study of their phenotypes in vivo using CRISPRi (Figure 2.1) to obtain facile and 
precise down-regulation. Using chemical genomics profiling and high-throughput microscopy, 
we identified complex phenotypes including chemical vulnerabilities (Figure 2.3), growth and 
shape phenotypes (Figure 2.4, 2.5), and terminal death phenotypes (Figure 2.6). Together, 
these revealed a complex web of connections among essential processes. Given that CRISPR 
systems are broadly active in bacteria, our approach can be readily extended to other bacterial 
species including pathogenic and non-culturable species.   
Our essential gene network (Figure 2.3) reveals numerous inter-process connections not 
previously annotated, and is highly enriched in novel connections among distant processes. 
Process inter-connectivity may provide the cell with mechanisms for restoring cellular 
homeostasis in response to transient imbalances. Some connections make intuitive sense. For 
example, folate is likely linked to replication via its necessity for dTTP synthesis. Such 
correlations readily suggest specific hypotheses that can be directly tested experimentally; e.g. 
a particular DNA polymerase subunit senses dTTP levels. Other connections have no facile 
explanation, and underscore the fact that connections between core processes are abundant 
and understudied. Very likely, our network significantly underestimates connections as it is 
based only on the highest confidence interactions to avoid false positives. Comparable datasets 
in other organisms will provide the basis for evolutionary studies to investigate the extent to 
which the logic of these functional circuits is conserved across organisms.  
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Our studies suggest that the levels of essential B. subtilis proteins are higher than necessary to 
maintain optimal growth, as the vast majority of basal knockdown strains grew indistinguishably 
from WT in exponential phase (Figure 2.4 B). Thus, either protein levels are set high enough to 
be robust to small (1.5-3-fold) decreases in expression or their levels are maintained by an 
elaborate posttranscriptional regulatory system. Moreover, there is a sufficient excess of 
essential proteins that most strains (70%) emerge from stationary phase even when their gene 
products are depleted during regrowth. The 30% of strains unable to exit stationary phase 
(Figure 2.13 A) are those whose protein levels are closest to the levels necessary for normal 
growth.  
In stark contrast, almost all basal knockdowns strains exhibited increased cell inviability during 
the exit from stationary phase. Thus, even a small decrease in protein product increases the 
vulnerability of cell regrowth (Figure 2.4 A). Importantly, there is little overlap between strains 
ceasing growth soon after depletion and those most vulnerable to inhibition of outgrowth from 
stationary phase (Figure 2.13 B). This discordance suggests that the set of essential genes 
whose expression level is close to that necessary for rapid cell growth in ideal conditions is 
distinct from the set necessary for survival during stationary phase. Speculatively, protein levels 
may reflect the ecological niche of B. subtilis in soil, where cells spend much time in a non-
growing state and must survive long enough to enter the sporulation program with high 
efficiency.  
Classically, genetic perturbations resulting in morphological variation, such as homeotic mutants 
and variegated maize, provided critical insights into fundamental cellular circuits. However, the 
essentiality or redundancy of most cell wall-synthesis proteins has made it difficult to uncover 
the molecular mechanisms underlying bacterial cell shape and size determination. Our CRISPRi 
knockdown approach allowed us to probe this relationship both under conditions of partial 
knockdown (1.5 to 3-fold) and during complete depletion. Partial knockdown identifies outliers 
exceptionally sensitive to depletion. As a consequence, we identified the critical envelope gene 
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actuators of the response, showed that cell width as well as length is controlled (Figure 2.5), 
and determined that cell width varies montonically with extent of depletion of mur genes (Figure 
2.5 D-E). The few outliers involved in other processes identify putative regulators of cell wall 
synthesis. The translation and DNA replication-related outliers may tie the rate of protein 
synthesis and DNA replication to cell-wall growth, possibly using previously unrecognized 
moonlighting functions of these proteins. Moreover, since maximal growth rate is not 
substantially affected across the basal knockdown strains, our findings indicate that cell size 
and growth rate can be at least partially decoupled. Additionally, a graded morphological 
response to the levels of essential proteins may drive physiological heterogeneity enabling 
population adaptation to dynamic environments.  
In contrast, complete depletion probes the intimate relationship between growth and 
morphology. Here, cells exhibit a wide array of terminal phenotypes with alterations in both 
growth and morphology (Figure 2.6 A). By comparison, only a single nonessential E. coli gene 
deletion (rodZ) has a morphological phenotype (Shiomi, Sakai, and Niki 2008). Some 
phenotypes result from gradual depletion of function (Figure 2.6 C), which may mimic 
imbalances that occur transiently due to stochasticity in gene expression. Tracing changes at 
different rates of depletion may provide clues to the cellular program for morphology. Moreover, 
the dynamics of removing an essential function may be as important to growth and viability as 
the presence or absence of such a protein.  
The evolution of essential processes has remained largely mysterious. Long-term evolution 
experiments have detected many mutational events in the RNA polymerase complex, cell-wall 
synthesis, and cell-shape determination (Tenaillon et al. 2012), suggesting a great diversity of 
molecular adaptations, including to essential processes. The apparent excess abundance of 
most essential proteins (Figure 2.6 D-E) suggests that new functions could rapidly develop from 
the existing repertoire of proteins without compromising growth, possibly explaining the 
prevalence of moonlighting proteins (Huberts and van der Klei 2010). For example, actin and 
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tubulin homologs have diverse roles in bacteria and eukaryotes (Busiek and Margolin 2015). 
Phenotypic heterogeneity and variable survival during stationary phase, as observed here 
(Figure 2.4), may indicate that stressful environments have shaped the evolutionary history of 
essential genes. The complexity of the network (Figure 2.3 A) suggests context dependence 
that may be critical for the evolution of essential genes and their interactions; perhaps certain 
essential genes can be rendered non-essential in environments such as biofilms. Expansion of 
our study to varied environments may provide a more nuanced view of the instances when a 
particular process is limiting for growth.  
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EXPERIMENTAL PROCEDURES 
 
CRISPRi Library Design, Cloning, Chemical Screens, and Growth Analysis 
sgRNAs targeted all putative essential genes (subtiwiki.uni-goettingen.de) and those recently 
identified in our B. subtilis gene knockout library (Koo et al. 2017). sgRNAs were designed to 
target within the gene body near the 5´ end of the gene on the non-template strand. sgRNA 
libraries were cloned via inverse PCR as previously described (Larson et al. 2014) and strains 
were constructed using natural competence transformation. Chemical screening was performed 
and chemical-gene scores were calculated as previously described (Nichols et al. 2011). B. 
subtilis and S. aureus UppS proteins were purified using nickel-affinity chromatography, and 
assayed using a Kinetic EnzCheck pyrophosphate assay (Life Technologies). The B. subtilis 
essential gene network was constructed by calculating all pairwise Pearson correlations 
between sgRNA knockdown strains, randomly permuting gene identity relative to chemical-gene 
scores to generate a background distribution, then applying a significance cutoff to the 
correlations based on the 95% confidence interval of the background distribution. Population 
growth curves were obtained from a microplate reader, and growth information was extracted by 
fitting the curves to a Gompertz equation (Zwietering et al. 1990). 
 
High-throughput Microscopy 
Images of single cells were acquired after transferring cells from a 96-well plate onto a large-
format agarose pad. Analysis of cellular morphologies was performed using custom MATLAB 
code. A minimum of 100 cells were analyzed for quantitative descriptions of single-cell 
phenotypes. Terminal phenotypes were examined by spotting cultures outgrown from stationary 
phase for two hours in liquid LB medium, transferred to agarose pads containing LB + 1% 
xylose, then imaged after overnight incubation. Time-lapse images were taken in an active-
control environmental chamber at 37 °C (HaisonTech). Further details of methods are in the 
Extended Experimental Procedures.  
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FIGURES 
 
Figure 2.1. B. subtilis CRISPRi is Efficient, Titratable, and Specific. 
A) B. subtilis xylose-inducible dCas9 is directed to specific DNA targets by constitutively 
expressed sgRNAs, where it represses transcription. dcas9 was stably integrated into the lacA 
locus, and sgRNAs into amyE or thrC. 
B) Flow cytometry of cells that constitutively express rfp and an rfp-targeted sgRNA, in which 
dcas9 was induced by adding the specified concentration of xylose. Median RFP levels are 
relative to the no-sgRNA control (grey dashed line), and error bars are ±1 standard deviation. 
C) RNA-seq of cells maximally induced for dcas9 (1% xylose) and constitutively expressing rfp 
and an rfp-targeted sgRNA versus cells without an sgRNA. Reads per gene were normalized by 
reads per kilobase per million reads. The dashed line is y = x. 
D) NET-seq of cells maximally induced for dcas9 (1% xylose) and constitutively expressing rfp 
and an rfp-targeted sgRNA versus cells without an sgRNA. The y-axis is broken to 
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accommodate the wide range of reads. The dashed line corresponds to the upstream boundary 
of the PAM sequence. We suggest that RNA 3´ end peaks upstream of the dCas9 block result 
from RNA polymerase queuing. 
E) Flow cytometry of cells maximally induced for dcas9 (1% xylose) and constitutively 
expressing an rfp-gfp operon and various rfp-targeting sgRNAs. RFP and GFP levels are 
relative to the no-sgRNA control. The dashed line is y = x. Note that in this group of sgRNAs, 
only template strand-targeting sgRNAs exhibited low efficacy (violet). 
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Figure 2.2. CRISPRi Knockdowns of Essential Genes Enable Discovery of Direct 
Antibiotic Targets. 
A) Relative fitness of CRISPRi essential gene knockdown strains (n = 289) with basal dcas9 
expression (no xylose induction) grown on plates containing MAC-0170636, as determined by 
the ratio of normalized colony sizes on LB plates + DMSO versus LB + MAC-0170636. 
B) Minimal inhibitory concentration (MIC) assay for strains over- or under-expressing uppS 
grown in liquid medium containing MAC-0170636. The MICs of these strains were (in µg/ml): 
sgRNAuppS + 0.05% xyl (~0.012), sgRNAuppS (~0.195), WT (~0.78), and uppS overexpression 
(~3.125). The values plotted are the means of at least three measurements, and error bars are 
±1 standard deviation. 
C) Concentration-dependent inhibition of purified B. subtilis UppS by MAC-0170636. Each point 
is an individual measurement. 
D) MIC assay for strains expressing B. subtilis uppS (Bs∆uppS/amyE::Pspank-uppSBs) or S. 
aureus uppS (Bs∆uppS/amyE::Pspank-uppSSa) grown in liquid LB + MAC-0170636. 
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Figure 2.3. An Essential Gene Network Reveals Numerous Intra- and Inter-
process Connections. 
A) Essential gene network based on correlations between chemical-gene phenotypes. Edge 
thickness is proportional to the extent of correlation. See also Figure 2.10 for network gene 
names. 
B) Intra- and inter-process connections between cell division and cell wall-biosynthesis genes. 
Genes outside the main network or genes lacking intra-process connections were excluded. 
C) ROC curve comparing connections between essential operons in our network to the STRING 
database. True-positive connections are those present in the high-confidence set of interactions 
from STRING, and false-positive connections are absent from STRING (these connections may 
be either truly false or novel). 
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D) Annotation distance for network connections between essential operons present or absent 
from the STRING database. Genes with an annotation distance of 0 are from the same 
functional group, while genes with an annotation distance of 4 are unconnected by annotation. 
E) Functional annotations for intra-process connections between essential operons present in 
the STRING database or present in our essential network. 
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Figure 2.4. High-resolution Growth Profiles of Essential Gene Knockdowns 
Reveal Widespread Defects in 
Stationary-phase Survival. 
A) Microplate reader growth curves of essential gene knockdown library strains. We grew cells 
for 18 h in LB before back-diluting into fresh LB (t = 0). Shaded area is mean ± standard 
deviation (S.D.) for the no-sgRNA control, n = 23. 
B) Growth curves from A with the apparent lag time of each strain shifted to zero. Shaded area 
is mean ± S.D. for the no-sgRNA control, n = 23. 
C) Data extracted from single-cell, time-lapse microscopy of selected essential gene knockdown 
strains grown on agarose pads with fresh LB after liquid growth in LB for 18 h. Although fewer 
mraY knockdown cells grow on LB pads after 18 h (11% versus 87% for the no-sgRNA control), 
the growth rate of elongating cells quantitatively matches that of the control (inset). 
D) Viable cell plating of selected essential gene knockdown strains grown in LB for 18 h. CFU: 
colony-forming units. 
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Figure 2.5. Partial Knockdown of Essential Genes Identifies Potential 
Morphological Regulators, with Envelope Gene Knockdown Leading to Changes 
in Cell Width. 
A) Cell volume of the no-sgRNA control varies substantially after 3.5 h of growth across dilutions 
of the same overnight culture into fresh LB. Cell length and width were highly correlated 
(Pearson’s R = 0.96, p<0.001). 
B) Median cell length and width of essential knockdown strains are highly correlated after 3.5 h 
of growth (Pearson’s R = 0.66, p<10-38). “Cell envelope” is the only functional category that is 
enriched in the outliers to the best-fit line (black) between length and width. Selected non-cell 
envelope outliers in DNA replication (blue) and translation (orange) are also shown. 
C) Distribution of cell widths of mbl and mreB knockdown strains at OD600~0.3 reveals subtle 
distinctions between the two actin homologs, with mbl cells wider than no-sgRNA control cells 
and mreB cells adopting a broader range of widths. n > 2000 cells for each histogram. 
D) Knockdown strains in the mur pathway have similar median cell length at OD600~0.3, while 
cell width varies over a wide range. Bars represent standard error of the mean.  
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E) Cell width of the murB knockdown strain increases monotonically with the degree of dcas9 
induction, in contrast to the no-sgRNA control. 
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Figure 2.6. Essential Gene Depletion Reveals a Diversity of Terminal Phenotypes.  
A) (i) Area-proportional graph of the fraction of essential gene knockdowns that give rise to 
morphological and growth terminal phenotypes. (ii-viii) Single-cell imaging of common terminal 
phenotypes of essential-gene knockdowns, with bar graphs depicting the broad functional 
categories underlying each terminal phenotype. 
B) Matrix of the similarity of terminal phenotypes achieved by genes belonging to the most 
common essential-gene functional groups. b.s., biosynthesis. 
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C) Titrated depletion of the valS knockdown and inhibition of WT by serine hydroxamate led to 
similar trends in terminal phenotypes, from over-division to filamenting and bending, and finally 
growth halting. 
D) Post-induction growth rates of selected strains with different terminal phenotypes. Most 
strains reduced growth rates by 20-30% in the first hour, except for murD and mbl. murD had a 
larger decrease in growth rate, whereas mbl had a similar growth rate as the no-sgRNA control. 
E) Morphological phenotypes during depletion post-CRISPRi induction. Phenotypes were 
observable by 40-60 min post-induction. 
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Figure 2.7. Multiplexed CRISPRi Knockdowns Facilitate Genetic Analysis of 
Complex Pathways. 
A) Schematic of knockdown of eight genes in a single cell. Knockdowns correspond to the 
genes in (B). 
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B) Quantitative PCR of RNA levels in the eight-gene knockdown strain at maximal dcas9 
induction (1% xylose). Expression is relative to the no-sgRNA control. Points are the means of 
at least three measurements, and error bars are ±1 standard deviation. 
C) The difference between measured and predicted fitness (ε, Extended Experimental 
Procedures) for each pbp double knockdown based on normalized colony size at maximal 
dcas9 induction (1% xylose). Negative and positive ε represent reduced or improved fitness, 
respectively. 
D) Measured versus predicted fitness of pbp triple knockdowns based on normalized colony 
size at maximal dcas9 induction (1% xylose). 
E) Terminal phenotypes of pbp knockdown strains. Arrows indicate lysed cells. 
F) Box plots of cell length from pbp knockdowns in E. n > 100 cells for each strain.  
G) Box plots of cell curvature from pbp knockdowns in E. n > 100 cells for each strain. 
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EXTENDED EXPERIMENTAL PROCEDURES 
Plasmid Construction 
Plasmids are available from the Bacillus Genetic Stock Center (http://www.bgsc.org/). dcas9 
was PCR-amplified from pdCas9-bacteria (Addgene #44249) using primers containing BamHI-
compatible BsaI sites, digested with BsaI, then ligated into plasmid pAX01 digested with BamHI 
to generate pJMP1 (Pxyl-dcas9, ErmR). The rfp-targeting sgRNARR1 was PCR-amplified from 
pgRNA-bacteria (Addgene #44251) using primers containing the veg promoter and EcoRI sites, 
digested with EcoRI, then ligated into either pDG1662 digested with EcoRI to generate pJMP2 
(Pveg-sgRNARR1, CmR), or pDG1731 digested with EcoRI to generate pJMP3 (Pveg-sgRNANT1, 
SpcR). Essential gene and pbp library plasmids were generated from either pJMP2 or pJMP3 
using inverse PCR as previously described (Hawkins et al. 2015; Larson et al. 2013). uppSBs 
was PCR-amplified from B. subtilis 168 genomic DNA using primers containing SalI and NheI 
sites, digested with SalI and NheI, then ligated into pDR110 digested with BamHI to generate 
pDR-uppSBs (Pspank-uppSBs, SpcR). uppSBs was PCR-amplified from S. aureus N315 genomic 
DNA using primers containing HindIII and SphI sites, digested with HindIII and SphI, then 
ligated into pDR110 digested with HindIII and SphI to generate pJMP11 (Pspank-uppSSa, SpcR). 
Multiple sgRNA plasmids were constructed using BsaI-mediated cloning as previously 
described (Hawkins et al. 2015), except for double pbp sgRNA plasmids, which were 
constructed by Gibson assembly (Gibson et al. 2009) using the Gibson Assembly master mix kit 
(New England Biolabs). 
Strain Construction 
Strains are available from the Bacillus Genetic Stock Center (http://www.bgsc.org/). All B. 
subtilis strains were constructed using natural competence via either a standard or high-
throughput method (Koo et al. 2017). 
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Standard Method
3 ml of MC medium (10.7 g/L potassium phosphate dibasic, 5.2 g/L potassium phosphate 
monobasic, 20 g/L glucose, 0.88 g/L trisodium citrate dihydrate, 0.022 g/L ferric ammonium 
citrate, 1 g/L casein hydrolysate, 2.2 g/L potassium glutamate monohydrate, 20 mM magnesium 
sulfate, 150 nM manganese chloride, 20 mg/L tryptophan) were inoculated with a single colony 
of B. subtilis and incubated at 37 °C overnight (≥10 h). The overnight culture was diluted to an 
OD600 of 0.1 in 10 mL BMK medium (10.7 g/L potassium phosphate dibasic, 5.2 g/L potassium 
phosphate monobasic, 20 g/L glucose, 0.88 g/L sodium citrate dihydrate, 0.022 g/L ferric 
ammonium citrate, 2.5 g/L potassium aspartate, 10 mM magnesium sulfate, 150 nM 
manganese chloride, 40 mg/L tryptophan, 0.05% yeast extract), then grown in a 125 mL flask at 
37 °C with shaking (250 rpm) until cells reached OD600~1.5. 150 µL of culture were then mixed 
with ≥100 ng of plasmid DNA in a deep 96-well plate, covered with a breathable film, and 
incubated at 37 °C without shaking for 10 min, then incubated at 37 °C with shaking (900 rpm) 
for 2 h. After 2 h, cells were plated on LB agar containing selective antibiotics (7.5 µg/mL 
kanamycin, a combination of 1 µg/mL erythromycin and 15 µg/mL lincomycin, 6 µg/mL 
chloramphenicol or 100 µg/mL spectinomycin [by activity]). 
High-throughput Method 
Double and triple pbp knockdown libraries were constructed using high-throughput 
transformation. Individual wells of a deep 96-well plate containing 300 µL of MC medium were 
inoculated with single colonies of strains containing Pxyl-dcas9 and an sgRNA targeting one of 
the 16 pbp genes; this plate was incubated at 37 °C with shaking (900 rpm) for at least 10 h. 
Cells were then diluted to OD600~0.1 in BMK medium, and 25 µL of diluted cells were added to 
≥100 ng of plasmid DNA in a shallow, v-bottom 96-well plate, covered with a breathable film, 
and incubated at 37 °C in a humidified incubator without shaking for 16 h. 50 µL of LB were 
added to each well and the well contents were plated on LB agar containing selective 
antibiotics. 
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Flow Cytometry 
Strains were grown overnight in LB in deep 96-well plates, and then back-diluted 1:300 into 
fresh LB containing the appropriate concentration of xylose to induce expression of dcas9. After 
~5 h of growth, cells were diluted 1:300 into phosphate buffered saline, and red fluorescence 
levels (B-A laser) were determined using an LSRII flow cytometer (BD Biosciences). Data for at 
least 10,000 cells were collected. Median red fluorescence signals were extracted from FCS 
files using FlowJo (FlowJo, LLC); error bars are from three biological replicates. 
 
RNA-seq 
Cells were grown in LB or LB + 1% xylose to OD600~0.3. RNA extraction and RNA-seq was 
performed as previously described (Larson et al. 2013). RNA-seq data was deposited at the 
Gene Expression Omnibus (GSE74926). 
 
NET-seq 
Cells were grown in LB + 1% xylose to OD600~0.3. NET-seq was performed as previously 
described (Larson et al. 2014). NET-seq data was deposited at the Gene Expression Omnibus 
(GSE74926). 
 
sgRNA Design 
The 20-nucleotide guide sequences for our sgRNA library were designed to be effective and 
specific. We first found all GG dinucleotides in the target genome, and extracted the 20 bases 
ending one base 5' of that GG as the potential target candidates for the organism. We then 
scored the specificity of each 20-nt guide by passing all the guides through Bowtie with the 
genome as the reference, then passing each 19-nt suffix through Bowtie, then each 18-nt suffix, 
etc. The score for a guide was the shortest suffix for which only a single alignment was found. 
Lower specificity score numbers were therefore better. If we never found a unique alignment at 
any length, the score was listed as -1, and the guide was avoided. Next, we annotated each 
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target with any coding regions overlapping that target. We noted the position of the target 
relative to the first coding base of the gene. For each gene we chose a target that was as close 
as possible to the 5' end of the coding sequence for that gene and that had a low (good) 
specificity score. 
 
sgRNA Efficacy Analysis 
To test the efficacy of our essential gene knockdown library, we pinned the library onto 
rectangular LB agar plates containing 1% xylose to fully induce expression of dcas9. Of the 299 
strains in the library, 258 targeted bona fide essential genes as determined by a gold-standard 
gene deletion analysis that attempted to replace every open reading frame in the B. subtilis 
genome with an antibiotic resistance marker (Koo et al. 2017). 244 of the 258 (95%) strains 
showed a colony size defect of at least 25% (Table 2.2). We then tested the 14 strains that 
failed to show a colony size defect by measuring growth in liquid LB + 1% xylose using a 
microplate reader. We found that 5 of the 14 strains showed 50% or less growth compared to 
the growth of the no-sgRNA control at mid-log phase (OD600~0.2; Table 2.2), bringing the 
percentage of effective sgRNAs to 97%. Of the nine strains that failed to show growth defects, 
five target phage genes; these genes may not be truly essential, as the antibiotic resistance 
marker used in the deletion analysis contains a strong promoter that may upregulate adjacent, 
toxic phage genes that are normally transcriptionally silent. Alternatively, dCas9 may be acting 
to repress phage transcription that is normally toxic (this appears likely for sgRNAs targeting the 
SKIN element repressor, sknR/yqaE). In the cases of yezG (a putative antitoxin) and yhdL (anti-
SigM), CRISPRi repression of upstream genes on the same transcript appears to also silence 
expression of toxic proteins normally controlled by these gene products. We conclude that 
nearly all sgRNAs targeting essential genes showed repression activity. 
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Quantitative PCR 
Overnight LB cultures of B. subtilis were diluted 1:1000 in 2 mL LB + 1% xylose. These liquid 
cultures were grown for 6 h at 37 °C. For RNA extraction, 600 µL of culture were mixed with 600 
µL of -20 °C methanol and spun down at full speed for 5 min. Once decanted, the RNA was 
extracted with the Qiagen RNeasy RNA isolation kit protocol #7. Following RNA isolation, 
genomic DNA was eliminated with the Ambion DNA-Free kit per manufacturer’s instructions. 
cDNA was synthesized with the Invitrogen SuperScript III First-Strand Synthesis System. 
Random hexamers were annealed, and then cDNA was synthesized via SuperScript III RT. 
cDNA was diluted 10-fold to be used in conjunction with Agilent Brilliant II SYBR Green QPCR 
Master Mix and 0.6 µM final concentration primers. Primers were designed with Primer3 with the 
following parameters: 60 °C melting temperature, 200 base pair-amplified region, and amplified 
region within the middle of the gene. Control genes employed consisted of sigA, gyrA, and rpoB. 
The qPCR included RNA samples that had DNase treatment, as well as RNase treatment, to 
verify that no genomic DNA remained. qPCR experiments were conducted in a Stratagene 
Mx3005P qPCR System. Three biological replicates were used in each qPCR. 
 
CRISPRi pbp Double and Triple Knockdown Screening 
Double and triple knockdown strains containing two sgRNA plasmids that integrate at either 
amyE or thrC were constructed using the high-throughput transformation method described 
above. Single colony isolates were stored as glycerol stocks in 96-well format. To screen the 
library, cells were robotically pinned from glycerol stocks onto rectangular LB agar plates in 384-
colony format using a ROTOR robot (Singer Instruments), then pinned once more to 1536-
colony format. Cells in 1536-colony format were then pinned to LB + 1% xylose plates to fully 
induce dcas9 expression. LB plates with PBP inhibitors also contained 1% xylose.. Plates were 
imaged using a Powershot G10 camera (Canon) after ~7-9 h of growth at 37 °C, and colony 
size was extracted using the “opacity” setting in the Iris software package (Paradis-Bleau et al. 
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2014). Colony size was normalized within plates using internal controls that expressed dcas9, 
but did not contain sgRNAs. 
The fitness (W) of double (or higher-order) deletion strains can be predicted by multiplying the 
fitness values of each of the single deletions (deletions of gene x and gene y) that comprise the 
double (predicted Wxy = Wx × Wy); this is known as the multiplicative model (St Onge et al., 
2007). Large values of the deviation between the measured fitness and the predicted fitness of 
double deletions (ε = measured Wxy – predicted Wxy) indicate a genetic interaction. Because our 
PBP genetic interaction screen used CRISPRi knockdowns rather than gene deletions, it was 
unclear if the multiplicative rule would apply to our analysis. To test for agreement between the 
multiplicative model and our CRISPRi screen data, we plotted predicted fitness versus 
measured fitness for all double knockdown strains (Figure 2.14 A). We found a strong, linear 
correlation (Pearson’s R = 0.95) between predicted and measured fitness, suggesting that the 
multiplicative model can reliably be applied to our CRISPRi knockdown data. The small 
deviation we observed from the ideal multiplicative model (ideal fit: y = x; our fit: y = 0.81x+0.13) 
may be due to the relatively small sample size of our screen (n = 240 double knockdowns).  
 
MAC-0170636 Screening and UppS Activity Assay 
Cloning, Overexpression, and Purification of B. subtilis UppS 
The gene uppS (GeneBank sequence NC_000964.3) was cloned into the pET-19b vector 
(Novagene) modified to encode an engineered Tobacco Etch Virus (TEV) protease cleavage 
site using primers uppS_FWD: CTAGCATATG CTCAACATACTCAAAAATTG and uppS_REV: 
CTAGCTACGAG CTAAATTCCGCCAAA. Primers used to generate the construct are listed 
below. UppS was over-expressed in E. coli BL21 (Rosetta) using auto-induction (Studier 2005). 
Cells were harvested by centrifugation at 6000 × g for 25 min at 4 °C. Cells were suspended in 
lysis buffer containing 50 mM NaH2PO4 (pH 8.0), 300 mM NaCl, 10 mM imidazole, 250 KU 
rLysozyme (Novagen) and an EDTA-free protease inhibitor tablet (Roche Diagnostics). Cells 
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were lysed using a cell disrupter (Constant Systems Limited, Daventry, UK). Lysates were 
cleared by centrifugation at 30,000 × g for 30 min at 4 °C. Nickel-affinity chromatography was 
performed on the lysates using a 30 mL free-flow gravity column and 5 mL of Ni-NTA agarose 
(Sigma). Once loaded, the column was washed with buffer (10 column volumes) containing 50 
mM NaH2PO4 (PH 8.0), 300 mM NaCl, 20 mM imidazole. His-tagged UppS was then eluted in 
buffer containing 50 mM NaH2PO4 (PH 8.0), 300 mM NaCl, 250 mM imidazole. Elution fractions 
were dialyzed overnight against 20 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 1 mM DTT. Once 
dialyzed, the elution fraction was concentrated using Amicon Ultra centrifugation filters (10kDa 
cut-off) and quantified using a NanoDrop (Thermo Scientific). 
Assay for UppS Inhibition by MAC-0170636  
A Kinetic EnzCheck pyrophosphate assay (Life Technologies) was used to assess inhibition of 
MAC-0170636 in vitro in accordance with the manufacturers guidelines. The IC50 value was 
determined in 100 μL reaction volumes using a flat bottom 96-well plate (Costar 3370) in 
duplicate. Reactions with varying concentrations of MAC-0170636 were conducted with a final 
concentration of 1% DMSO in the presence of 0.2 mM 2-amino-6-mercapto-7-methyl-purine 
ribonucleoside (MESG), 0.625 U of purine ribonucleoside phosphorylase (PNP), 0.2 U of 
inorganic pyrophosphatase (PyroP), 0.125 μg of purified UppSBs enzyme, 0.82 μM farensyl 
pyrophosphate (FPP) (1xKM) and 65 μM isopentenyl pyrophosphate (IPP) (5x KM). For UppSSa, 
0.5 μg of purified UppS enzyme, 0.7 μM farensyl pyrophosphate (FPP) (1xKM), and 80 μM 
isopentenyl pyrophosphate (IPP) (5x KM) were used in the reaction. Data were fit using GraFit 
V5 (Erithacus Software). 
 
CRISPRi Essential Gene Knockdown Screening and Network Construction 
Essential Gene Knockdown Screening 
sgRNA plasmids were transformed into a strain containing dcas9 (CAG74209) using the 
standard method described above. Single colony isolates of each transformation were grown 
 45 
overnight in LB + 6 µg/mL chloramphenicol, and stored as glycerol stocks at -80 °C in 96-well 
plates. Prior to screening, cells were robotically pinned onto rectangular LB agar plates in 384-
colony format, and then pinned once more to 1536-colony format using a ROTOR robot (Singer 
Instruments). To screen the essential library, we pinned from rectangular LB agar plates in 
1536-colony format to plates containing the indicated concentration of antibiotic or chemical 
stress. Each plate contained four technical replicates for each sgRNA strain and each chemical 
concentration was replicated at least twice; most concentrations had four replicate plates. 
Chemical concentrations were empirically determined by streaking wild-type B. subtilis 168 onto 
round agar plates containing chemicals and then visually inspecting the plates for colony size 
defects. We used concentrations in our screen that inhibited growth by 50% or less; chemical 
concentrations that inhibited growth such that the median colony size after 14 h was less than 
the median colony size on LB after 7 h were discarded. Importantly, the effective concentration 
of chemical in our screening plates is likely to be lower than the concentration added to the plate 
because of chemical breakdown during the two-day period in which plates were dried at room 
temperature to reduce problems with colony smearing due to wet plates. Pinned cells were 
grown on rectangular plates for 7-14 h at 37 °C, and then imaged using a custom light box with 
a Canon Powershot G10 (Canon). 
Data Analysis and Network Construction 
Colony sizes were extracted from plate images using the Iris software package (Paradis-Bleau 
et al. 2014). Spatial effects were normalized using a quadratic function, median and variance of 
colony sizes were normalized between plates, and S-scores were computed using previously 
developed software (Collins et al. 2006). False discovery rates were computed from S-scores as 
previously described (Nichols et al. 2011). 
To construct an essential gene network from gene-chemical scores (i.e., S-scores), these 
scores were correlated (Pearson correlation) in a pairwise manner for all sgRNA knockdown 
strains, resulting in ~90,000 gene-gene correlations. To establish a cutoff for correlation 
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significance, we estimated the background distribution of correlations by randomly permuting 
gene identity relative to the chemical-gene scores 5,000 times, and then used the 95% 
confidence interval of this background distribution (after discarding self correlations that equaled 
1) to establish a correlation significance threshold of 0.572 (method adapted from Nichols et al., 
2011); this procedure resulted in 412 significant connections between distinct sgRNA 
knockdown strains. Network data was visualized using Cytoscape v3.2.1 (Cytoscape 
Consortium) (Shannon et al. 2003). 
Network Comparison to the STRING Database 
Essential operons were defined based on manual curation of global expression data (Nicolas et 
al. 2012) and functional annotations from the SubtWiki database (http://subtiwiki.uni-
goettingen.de/). For any essential operon with genes in different annotations, the operon was 
split into subsets of genes with the same annotation; correlations between genes in the same 
operon were eliminated from the analysis. Pairs of essential operons were defined as interacting 
if any pair of genes spanning both operons had a correlation above the threshold value 0.572. 
The connectivity between two functional groups was defined as the number of essential operon 
interactions between the two groups. If two genes within the same essential operon fell into 
distinct functional groups, the interaction between them did not contribute to the functional group 
connectivity. Similarly, the interaction between operons that have been classified as single 
operons in other studies did not contribute to the functional group connectivity.  
Comparison to the STRING database was achieved by downloading the Bacillus subtilis 168-
specific interactions scores from http://string-db.org/ (Szklarczyk et al. 2015). Scores were 
culled to the “experimental” or “database” categories. Genetic interactions in the STRING 
database were combined into essential-operon interactions in an equivalent manner to our 
chemical genomics data. 
Annotation distance analysis between essential gene operons was performed using annotations 
from the SubtiWiki online database (http://subtiwiki.uni-goettingen.de/). SubtiWiki annotations 
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are broken down into four levels: the first level is very general (e.g., metabolism) and the fourth 
level is specific (e.g., RNA polymerase). In cases in which there were only three levels of 
annotation, the annotation from the third level was also used for the fourth level (Table 2.3). 
Operons with the same annotation at the fourth level (most specific) were given an annotation 
distance of 0, while operons with no overlapping annotations were assigned a 4. As the 
annotation distance was subject to bias based on the extent of annotation (e.g., whether or not 
strains were annotated at the fourth level), we suggest that the distance be interpreted as a 
qualitative metric for annotation differences. 
 
High-resolution Liquid Growth Curve Acquisition and Analysis 
All strains were grown in deep 96-well plates for 18 h, then back-diluted 1:200 into 200 μL fresh 
LB (for induced growth curves, LB was supplemented with 1% xylose, and the overnight 
cultures were grown for 26 h) and grown with shaking at 37 °C in an Infinite M200 plate reader 
(Tecan) for 7 h. The absorbance at wavelength 600 nm (OD600) was measured at 7.5-min 
intervals.  
For uninduced growth curves, the natural logarithm of the optical density was fit to the Gompertz 
equation (Zwietering et al. 1990) to determine apparent lag time, maximum specific growth rate, 
and from that, the doubling time. Each growth curve was fit individually. 
For induced growth curves, several criteria were used to classify the curves into different 
categories: 1) no growth: OD600<0.06 throughout the measurement; 2) linear growth: final 
OD600>0.2, Pearson correlation coefficient >0.98 between time and OD600 after removal of the 
lag and saturation regions of the curve, and the slope at the end of the growth phase is >90% of 
the slope at the beginning of growth; 3) growth and death: maximum OD600 is >1.2 × the final 
OD600, with final OD600>0.06; 4) others: strains that do not fall into any of the previous three 
categories. 
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Viable Counts 
Strains were grown in deep 96-well plates for 18 h. The OD of each overnight culture was 
measured using a Genesys 20 spectrophotometer (Thermal Scientific). Overnight cultures were 
serially diluted in LB, and at each dilution, 100 µL of culture were plated on LB. Plates were 
incubated overnight at 37 °C, and the dilutions with ~100 colonies were used to count the 
number of colony forming units (CFUs). 
Each overnight culture used for CFU counting was also diluted 1:100 in fresh LB, and 1 μL of 
the diluted culture was spotted onto a pad of 1.5% agarose in fresh LB. The pads were 
incubated at 37 °C for 2 h and then imaged. Dead or non-growing cells remained small and 
isolated from other cells, and live cells grew into collections of larger cells. The number of 
dead/non-growing cells and live cells were manually counted for each strain; a total of at least 
200 cells were counted for each strain. 
 
High-throughput Imaging and Analysis 
For phase-contrast and fluorescence imaging, cells were imaged on a Nikon Eclipse TE 
inverted fluorescence microscope with a 100X (NA 1.40) oil-immersion objective. Images were 
collected using an Andor DC152Q sCMOS camera (Andor Technology, South Windsor, CT, 
USA) and µManager v1.3 software (Edelstein et al. 2010). For time-lapse imaging, cells were 
maintained at 37 °C during imaging with an active-control environmental chamber 
(HaisonTech). 
Custom MATLAB (MathWorks) image processing code was used to segment cells and identify 
active cell contours from phase microscopy (Monds et al. 2014; Ursell et al. 2014). Cell widths 
and lengths were calculated using the MicrobeTracker meshing algorithm (Sliusarenko et al. 
2011). For all single-cell quantification, at least 100 cells were analyzed for each strain. 
Enrichment of morphological defects in each functional group was identified by conducting a 
two-sample KS test between the average length trend line deviations of strains corresponding to 
a functional group, and the entire collection background. For pbp strains, cell lengths were 
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approximated by half of the contour lengths, and cell bending was defined as the minimum 
negative curvature of the cell contour. 
 
Terminal Phenotypes 
Microscopy  
Cells were back-diluted 1:200 from overnight culture into fresh LB and grown at 37 °C for 2 h in 
a plate shaker, and then 1 μL of cells was spotted onto a pad of 1.5% agarose in fresh LB 
supplemented with 1% xylose. Cells were incubated on the pads overnight at room temperature, 
and then imaged. For imaging under antibiotic treatment and xylose titration, the appropriate 
concentrations of antibiotics or xylose were added to the agarose pads. For staining, 1 μg/ML 
DAPI (Invitrogen) and/or 2 μg/mL FM4-64 (Invitrogen) were added to the pads. 
Analysis 
Terminal phenotype for each essential gene knockdown was manually classified using an eight-
dimensional phenotype vector encompassing features of lysis, bulging, uniform shape loss, 
bending, filamentation, over-division (shorter cells), and level of post-induction growth. Severe 
bulging, filamentation, or lysing phenotypes were classified as dominant such that secondary 
phenotypes were ignored. A given functional group of essential operons was described by its 
fractional composition of terminal phenotypes from essential operons in that group. The cosine 
similarity of terminal phenotypes between functional groups was calculated between the 
normalized fractional composition vectors. 
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SUPPLEMENTAL FIGURES 
 
Figure 2.8. Further Characterization of the B. subtilis CRISPRi System, Related to 
Figure 2.1. 
A) Flow cytometry of cells constitutively expressing rfp, with or without Pxyl-dcas9 and an rfp-
targeting sgRNA. RFP levels are relative to the sgRNA- control. 
B) Flow cytometry of cells constitutively expressing rfp, with or without PIPTG-dcas9 and an rfp-
targeting sgRNA. RFP levels are relative to the sgRNA- control. rfp knockdown without IPTG 
induction is <15%. 
C) Flow cytometry of cells in which dcas9 was induced by adding the specified concentration of 
xylose that constitutively express rfp and an rfp-targeting sgRNA shown as distributions of RFP 
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fluorescence for selected xylose concentrations. RFP levels per cell are relative to the sgRNA- 
control. 
D) NET-seq of cells maximally induced for dcas9 (1% xylose) and constitutively expressing rfp 
and an rfp-targeted sgRNA versus cells without an sgRNA. Bars show the total number of 
normalized RNA 3´-ends downstream of the sgRNA-dCas9 binding site. 
E) Flow cytometry of cells constitutively expressing an rfp-gfp operon and various sgRNAs 
targeting gfp at maximal induction of dcas9 (1% xylose). RFP and GFP levels are relative to the 
sgRNA- control. The dashed line is y = x. Note that the sgRNAs with low efficacy target the 
template strand (violet). 
F) Growth curves of Pxyl-dcas9 sgRNA- (red), Pxyl-dcas9 sgRNA+ (green), and B. subtilis 168 
cells (blue), with 1% xylose supplemented. Shaded areas are mean ± std for each strain. 
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Figure 2.9. Essential Gene Knockdown Screen Reproducibility and Chemical-
gene Phenotypes, Related to Figures 2.2 and 2.3. 
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A) Reproducibility between replicate colonies for all chemical conditions (R: Pearson’s 
correlation). 
B) Hierarchical clustering of chemical-gene scores (S-scores; (Collins et al., 2006)) for all 
chemical conditions. 
C) A tetrahydrofolate biosynthesis and utilization cluster defined by knockdown strain sensitivity 
to the DfrA inhibitor trimethoprim and the Sul inhibitor sulfamonomethoxine. 
D) A cell division/RNA polymerase cluster defined primarily by sensitivities to cell wall-acting 
antibiotics (aztreonam, cefoxitin, D-cycloserine, and fosfomycin) and DNA intercalators 
(ethidium bromide, and acriflavine). 
E) Concentration-dependent inhibition of purified S. aureus UppS by MAC-0170636. Each point 
is an individual measurement. 
F) A cluster containing ylaN, isoprenoid biosynthesis, and iron-sulfur cluster biosynthesis genes 
defined by resistance to cell wall-targeting antibiotics, especially fosfomycin. 
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Figure 2.10. An Essential Gene Network Reveals Numerous Intra- and Inter-
process Connections, Related to Figure 2.3. 
The B. subtilis essential gene network as depicted in Figure 2.3 A, except showing sub-
networks with only one or two connections and gene labels. 
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Figure 2.11. Further Characterization of the Essential Gene Network and Basal 
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Knockdown Levels, Related to Figures 2.3 and 2.4. 
A) ROC curves depicting true positive rates and false positive rates for either intra- or inter-
process connections between essential operons. 
B) Absolute number of connections between essential operons in the STRING database (blue) 
or our essential network (red). 
C) Previously uncharacterized connections between cell division and transcription (red lines); 
these connections are largely due to shared sensitivities of ftsL/divIC and rpoB/C knockdowns 
to cell wall-acting antibiotics and DNA intercalators (see also Figure 2.9 D). Black lines are 
connections between genes in different operons and grey lines are connections within operons. 
D) RNA-seq of cells with basal expression of dcas9 and an sgRNA targeting rpoB versus cells 
without an sgRNA. Reads per gene were normalized by RPKM. The dashed line is y = x. The 
rpoBC transcript is reduced ~40% by the rpoB sgRNA. Outliers and genes of interest are 
colored as indicated. The operon containing manP/A-yjdF is abbreviated as “man.”  
E) Previously uncharacterized connections among iron-sulfur cluster biosynthesis, isoprenoid 
biosynthesis, and the gene of unknown function ylaN (red lines). Black lines are connections 
between genes in different operons and grey lines are connections within operons. 
F) ylaN is no longer essential in the presence of additional iron. B. subtilis 168 cells were 
transformed with PCR products that replaced either trpC (B. subtilis 168 is already mutant for 
trpC, so the replacement is neutral), or ylaN with a kanamycin-resistance marker. 
G) Basal CRISPRi knockdown of rfp modestly increases during stationary phase. 
H) Culture optical densities (ODs) determine the instantaneous growth rates for all strains. 
Instantaneous growth rates were calculated from OD measurements in Figure 2.11 A. Shaded 
area is mean ± std for sgRNA- control. 
 
 57 
Figure 2.12. Further Characterization of Cellular Dimensions and Terminal 
Depletion Phenotypes, Related to Figures 2.5 and 2.6. 
A) Median cell lengths for a subset of strains measured from both phase contrast images and 
FM4-64 staining. The two measurements are highly correlated. We note that our strains did not 
show as strong a propensity for chaining as other B. subtilis strains, and that it was possible to 
identify the positions of septa from phase contrast images.  
B) Cells from a subset of strains with representative terminal phenotypes stained with DAPI and 
FM4-64 to reveal nucleoid structure and the cell membrane, respectively. 
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C) Distribution of cell lengths of the valS knockdown strain in its terminal phenotype in LB vs. LB 
+ 0.005% xylose. Xylose-treated cells were significantly shorter and exhibited the overdivision 
phenotype. 
D) Distribution of cell lengths of wild-type cells in its terminal phenotype in LB vs. LB + 0.6 
mg/mL serine hydroxamate. Cells treated with serine hydroxamate were significantly shorter 
and exhibited the overdivision phenotype. 
E) Post-induction instantaneous growth rates for selected strains with different terminal 
phenotypes. Most strains maintained constant growth rates in the first hour, except for murD, 
which decreased in growth rate after 40 min. 
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Figure 2.13. Essential Gene Depletion Growth Curves, Related to Figure 2.6. 
Microplate reader growth curves of essential gene knockdown library strains at full induction of 
dcas9. Set of strains that displayed noteworthy growth patterns are plotted in each subfigure. 
A) The set of strains that never emerged from stationary phase with dcas9 induction. 
B) Strains in A) displayed a range of apparent lags without dcas9 induction, indicating that cell 
death during depletion is not correlated to vulnerability in stationary phase. 
C) Strains that continued growing after dcas9 induction. 
D) Strains that exhibited slower, almost linear growth curves. 
E) Strains that exhibited biphasic behavior, involving initial growth followed by stalling and a 
marked decrease in OD. 
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Figure 2.14. pbp Knockdown Specific Examples, Chemical Screens, and 
Reproducibility, Related to Figure 2.7. 
A) Relationship between double knockdown fitness predicted by the multiplicative model and 
fitness measured by colony size. The grey, dashed y = x line represents the ideal relationship 
between predicted and measured fitness according the multiplicative model; the red line is a 
linear fit to the data. Strains with two sgRNAs targeting the same gene were removed for clarity. 
B) Relative fitness defect of the pbpB single knockdown strain based on normalized colony size. 
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C) Agreement between normalized colony sizes for reciprocal double knockdown sgRNA pairs 
(e.g., amyE::sgRNApbpA and thrC::sgRNApbpH versus amyE::sgRNApbpH and thrC::sgRNApbpA) at 
maximal induction of dcas9 (1% xylose). 
D) The difference between measured and predicted fitness (ε values) for each pbp double 
knockdown based on normalized colony size at maximal induction of dcas9 (1% xylose) and in 
the presence of the indicated PBP inhibitor.  
E) Agreement between normalized colony sizes for reciprocal double knockdown sgRNA pairs 
at maximal induction of dcas9 (1% xylose) and in the presence of the indicated PBP inhibitor. 
 
Table 2.1. Strains, Plasmids, and Essential sgRNAs, Related to Figures 2.1, 2.2, 
2.3, 2.4, 2.5, 2.6, and 2.7. 
[INCLUDED AS SEPARATE FILE] 
Strains (Sheet 1) and plasmids (Sheet 2) used in this study, and sequences, annotations, and 
validation data for sgRNAs targeting essential genes (Sheet 3). 
 
Table 2.2. CRISPRi Essential Gene Knockdown Chemical Screens, Related to 
Figures 2.2 and 2.3. 
[INCLUDED AS SEPARATE FILE] 
Essential knockdown screen chemical conditions (Sheet 1), chemical-gene scores (calculated 
from at least eight replicates; Sheet 2), sensitivities of essential knockdown strains for their 
cognate antibiotics (Sheet 3), and colony size data (median of at least eight replicates) from the 
MAC-0170636 screen. 
 
Table 2.3. CRISPRi Essential Gene Knockdown Chemical Screen Correlations and 
Network, Related to Figure 2.3. 
[INCLUDED AS SEPARATE FILE] 
All gene-gene correlations from the essential knockdown screen (Sheet 1), significant gene-
gene correlations (0.572 correlation cutoff; Sheet 2), essential operon annotations (Sheet 3), 
and rpoB knockdown RNA-seq data (Sheet 4). 
 
Table 2.4. High-resolution Growth Profiles, Related to Figure 2.4. 
[INCLUDED AS SEPARATE FILE] 
Exponential growth rates and apparent lag times in basal knockdown conditions (Sheet 1), and 
categories of knockdown behavior during induced growth (Sheet 2). 
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Table 2.5. CRISPRi Essential Gene Knockdown Cell Morphologies, Related to 
Figures 2.5 and 2.6. 
[INCLUDED AS SEPARATE FILE] 
Uninduced cellular dimensions and deviation from expected cell shape based on correlation 
between length and width in Figure 2.5 B (Sheet 1), and terminal phenotypes of induced 
knockdown strains (Sheet 2). 
 
Table 2.6. Multiplexed CRISPRi pbp Knockdowns and Chemical Screen, Related 
to Figure 2.7 
[INCLUDED AS SEPARATE FILE] 
Normalized colony sizes for pbp double knockdowns on xylose, xylose + mecillinam (3 µg/ml), 
xylose + cefoxitin (0.2 µg/ml), and xylose + aztreonam (1µg/ml) (colony sizes are normalized to 
the plate control and are the median of at least eight replicates; Sheet 1), measured minus 
predicted fitness for all pbp double knockdown screens (Sheet 2), and normalized colony sizes 
for the pbp triple knockdown screen (Sheet 3). 
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Chapter 3 
Modulated efficacy CRISPRi reveals evolutionary 
conservation of essential gene expression-fitness 
relationships in bacteria 
 
SUMMARY 
Essential genes are the central hubs of cellular networks. Despite their importance, the 
lack of high-throughput methods for titrating their expression has limited our 
understanding of the fitness landscapes against which essential gene expression levels 
are optimized. We developed a modified CRISPRi system leveraging the predictable 
reduction in efficacy of imperfectly matched sgRNAs to generate specific levels of 
CRISPRi activity and demonstrate its broad applicability in bacteria. Using libraries of 
mismatched sgRNAs, we characterized the expression-fitness relationships of essential 
genes in Escherichia coli and Bacillus subtilis. Remarkably, these relationships co-vary 
by pathway and are predominantly conserved between E. coli and B. subtilis despite ~ 2 
billion years of evolutionary separation, suggesting that deeply conserved tradeoffs 
underlie bacterial homeostasis. 
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Main Text 
Bacteria must optimize protein production to maximize survival and growth in constantly 
changing environments. Given the high energetic cost of protein synthesis, optimizing 
expression is particularly important for essential genes: although only ~5-10% of the 
genome, they constitute a disproportionate fraction (~50%) of the proteome (Lalanne et 
al. 2018) and insufficient expression is, by definition, fatal. Previous work using 
promoter replacement revealed gene-, environment-, and antibiotic-specific fitness 
effects of altering essential gene expression (Bauer, Li, and Siegal 2015; Keren et al. 
2016; Dekel and Alon 2005; Eames and Kortemme 2012; Nichols et al. 2011; E. O. 
Johnson et al. 2019), but the lack of a facile method for systematically perturbing 
bacterial gene expression has thus far prevented a comprehensive understanding of 
how bacteria optimize expression of their essential protein complement. CRISPR 
interference (CRISPRi), which blocks bacterial transcription by targeting a catalytically 
dead Cas9 (dCas9) to a gene using a complementary sgRNA, has been used to perturb 
essential gene expression in its native context. However, tuning transcriptional 
repression by adjusting dCas9 or sgRNA abundance (Peters et al. 2016; Liu et al. 2017) 
is noisy and precludes the interrogation of multiple knockdown levels in a single 
experiment (Vigouroux et al. 2018). Building on previous work (Gilbert et al. 2014; 
Vigouroux et al. 2018), we reasoned that we could instead modulate transcriptional 
repression by programming a highly expressed CRISPRi system with sgRNAs 
imperfectly matched to their target. This would allow us to explore the fitness landscape 
of essential gene expression by enabling massively parallel interrogation of the fitness 
effects of multiple levels of CRISPRi activity across genes in a single pooled growth 
experiment. 
 65 
 
We first explored how mismatches affect sgRNA activity by generating a comprehensive 
library of sgRNA spacers targeting gfp (3201 total), consisting of all spacers fully 
complementary to the non-template strand (33), a majority of their possible single 
mismatch variants (47/60), and a subset of their possible double mismatch variants 
(49/1710) (Fig. 3.5 A). Using FACS-seq (Fig 3.1 A, Methods), we quantified the ability 
of these sgRNAs to repress transcription of a highly expressed chromosomal copy of 
gfp both in E. coli and B. subtilis (Fig. 3.5 A-C, Table 3.1). We found that sgRNAs with 
either single (Fig. 3.1 B) or double (Fig. 3.7 A) mismatches in their base-pairing regions 
generated the full range of repression (no efficacy to full efficacy) in both species. 
Importantly, sgRNA activity was unimodal (Fig. 3.6 E-H) and highly correlated between 
E. coli and B. subtilis (R2: singly mismatched sgRNAs = 0.65, doubly mismatched 
sgRNAs = 0.61, all sgRNAs = 0.71, Fig. 3.1 B. 3.7 A, and Table 3.1), despite an 
evolutionary distance of several billion years and differences in experimental setup (E. 
coli: plasmid-encoded sgRNAs, B. subtilis: chromosomally integrated sgRNAs). This 
suggests that the primary determinant of CRISPRi efficacy in bacteria is the interaction 
between the dCas9-sgRNA complex and DNA, rather than organism-specific factors 
such as the host’s transcriptional machinery.  
 
Given the species-independent performance of gfp-targeting mismatched sgRNAs, we 
next asked whether we could accurately predict the effects of single mismatches on 
sgRNA activity. Informed by previous work on CRISPRi off-target effects (Qi et al. 2013; 
Gilbert et al. 2014) and concurrent work on mismatched sgRNAs in a mammalian 
 66 
context (Jost et al. 2019), we constructed a linear model using the position and base 
substitution of the mismatch and the GC% of the fully complementary spacer as 
features. We trained this model on the E. coli, B. subtilis (Fig. 3.8, 3.9), or species-
averaged relative efficacy of our gfp-targeting singly mismatched sgRNAs (Fig. 3.1 C) 
and found that the effects of single mismatches could be robustly predicted in all cases 
(species-averaged R2 = 0.56, 11-fold CV-MSE = 0.10 +/- 0.08). Assuming that 
mismatches have independent effects on sgRNA efficacy, the model also accurately 
predicted double mismatch efficacy (R2 = 0.53, Fig. 3.7 B). To further validate this 
model, we compared our predicted sgRNA activity to the previously measured 
association rates (kon) of a dCas9-sgRNA complex to 60 singly mismatched and 1130 
doubly mismatched DNA sequences (Boyle et al. 2017) (Fig. 3.1 D, 3.3 C). Our 
predicted efficacy was highly correlated (R2: single mismatches = 0.71, double 
mismatches = 0.45) to the kon measured in this in vitro system, supporting the 
hypothesis that mismatched-CRISPRi functions by reducing the association rate of the 
dCas9-sgRNA complex for the target DNA. Consistent with this idea, our model 
recapitulates many biophysical properties of RNA-DNA interactions such as the relative 
stability of rG:dT basepairs implied by its high coefficient for A to G transitions 
(Sugimoto, Yasumatsu, and Fujimoto 1997) (Table 3.2 and Fig. 3.6 D). Taken together, 
these data strongly suggest that a simple linear model trained on the relative efficacy of 
our gfp-targeting singly mismatched sgRNA library can be used to design mismatched 
sgRNAs with a specific activity level targeting any gene.  
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Using our model of mismatched sgRNA activity, we designed a set of sgRNAs targeted 
to the essential gene complement of E. coli and B. subtilis (~300 genes in each species, 
Table 3.3) and predicted to have a range of activity. We generated large pooled 
libraries of strains in which each essential gene is targeted by 100 sgRNAs (10 fully 
matched guides each with 9 singly mismatched variants, Methods, Fig. 3.5 C) and 
compact libraries in which each essential gene is targeted by 11 sgRNAs (See Note 
3.1). Additionally, for two well characterized essential genes encoding UDP-GlcNAc-1 
carboxyvinyltransferase (E. coli: murA, B. subtilis: murAA), and dihydrofolate reductase 
(E. coli: folA, B. subtilis: dfrA), we generated comprehensive libraries (at least 47/60 
single mismatch variants for each sgRNA within the gene, Methods, Fig. 3.5 B). The 
libraries were grown for 10 doublings, maintaining exponential phase through back-
dilution (Fig. 3.2 A). We calculated the relative fitness (Rest et al. 2013; Kampmann, 
Bassik, and Weissman 2013) of each strain by comparing its relative abundance 
(quantified by next-generation sequencing of the sgRNA spacers) to the relative 
abundance of 1000 non-targeting sgRNAs at the start and end of each experiment 
(Methods, Table 3.3). Relative fitness is defined as the fraction of doublings a strain 
undergoes compared to wild-type over the course of the experiment. Strains with a 
relative fitness of 1 grow as well as wild-type; lower values imply slower growth. 
Relative fitness was highly reproducible in both species (R2 > 0.9, Fig. 3.10 A-B), was 
validated by orthogonal measurements of individual strain fitness (Fig. 3.10 C), and was 
consistent within fully complementary sgRNAs targeting the same gene (Sup. Text 1). 
Our relative fitness values were correlated with previously reported measurements 
(Tianmin Wang et al. 2018; Rousset et al. 2018) but had greatly expanded dynamic 
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range due to greater sequencing depth and a shorter growth period (Fig. 3.10 D-E, Sup. 
Text 2). This expanded dynamic range enabled measurement of negative relative 
fitness, which indicates active depletion from the pool. CRISPRi targeting of 23 E. coli 
genes and 24 B. subtilis genes reproducibly (>5 sgRNAs) caused negative relative 
fitness (Table 3.4). Consistent with an interpretation of negative relative fitness as lysis, 
a majority (15/24) of these B. subtilis genes caused lysis when targeted with a fully 
complementary sgRNA (Peters et al. 2016) (Table 3.4, Methods).  
 
We next assessed whether comparing the predicted activity of sgRNAs to their relative 
fitness would allow us to infer per gene expression-fitness relationships. First, we asked 
whether predicted sgRNA activity was inversely correlated to relative fitness across our 
data set. As expected, we found strong negative correlations both within sgRNA families 
(sgRNAs targeting the same locus) and within genes (Fig. 3.11, Methods). Weaker 
correlations in E. coli likely reflect variation in sgRNA plasmid copy number and/or E. 
coli specific effects (Cui et al. 2018). Second, we examined the expression-fitness 
relationships of murA/murAA and folA/dfrA using comprehensive mismatched sgRNA 
libraries. Consistent with previous studies (22-24), we find that CRISPRi targeting of 
murA/murAA bimodally affects fitness (Fig. 3.2 B-C), while CRISPRi targeting of 
folA/dfrA linearly affects growth rate above an initial threshold of activity (Fig. 3.2 D-E). 
Highlighting the approximately linear effect of folA/dfrA repression on fitness, our model 
could accurately predict gfp knockdown after being trained on the fitness effects of 
mismatched sgRNAs targeting those genes (Fig. 3.8, 3.9). Third, we measured the 
ability of 18 mismatched sgRNAs to repress a murAA-gfp transcriptional fusion in B. 
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subtilis. To enable quantification of lethal levels of knockdown and to minimize 
transcriptional feedback these measurements were conducted in a B. subtilis strain 
complemented with non-targeted murAA (Methods). The predicted activity of sgRNAs 
targeting murAA in this experiment closely tracked actual knockdown (Fig. 3.2 F), 
suggesting that the non-linear expression-fitness relationship of murAA without 
complementation (Fig. 3.2 B) reflect non-linearly decreasing growth due to MurAA 
depletion, transcriptional feedback,  cell lysis, or other host specific effects. Finally, we 
confirmed that low efficacy (relative fitness > 0.95) sgRNAs targeting dfrA were 
functional by measuring the fitness of the B. subtilis dfrA library in the presence of 
trimethoprim, a direct inhibitor of DfrA. Trimethoprim decreased the fitness of low 
efficacy sgRNAs targeting dfrA suggesting that these sgRNAs impact dfrA expression 
even in the absence of a measurable fitness defect (Fig. 3.2 G). Taken together, these 
validation experiments strongly suggest that we can accurately and sensitively probe 
the expression-fitness relationships of essential genes in E. coli and B. subtilis by 
comparing the predicted activity of mismatched sgRNAs to their measured fitness using 
a pooled screening approach. 
 
Examining the essential gene expression-fitness relationships, we were struck by their 
diverse and gene-specific nature (Fig. 3.12, 3.13, Table 2.3). To quantitatively 
characterize these differences, we first binned the sgRNAs targeting each gene 
according to predicted sgRNA activity and calculated the median fitness within each bin 
(Methods, Fig. 3.2 B-E, Table 3.5). Next, we used these simplified representations of 
per gene expression-fitness relationships to calculate pairwise distances between E. 
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coli and B. subtilis essential genes. Within each organism, we found that the 
expression-fitness relationships of genes involved in the same biological process 
(whether defined by KEGG, GO biological process, or COG) were significantly more 
similar to each other than to those of genes involved in different biological processes, 
even when excluding gene pairs in the same operon to account for CRISPRi polarity (all 
p < 10-16, Methods). Inversely, clustering genes by the shape of their expression-fitness 
curves produced functional enrichments (Table 3.6) in both E. coli and B. subtilis. 
Finally, in a cross-species comparison, the expression-fitness curves of essential genes 
were, as a group, more similar (p < 10-10) to that of their homologs than to other genes 
in the opposing species. Taken together, these data suggest that these expression-
fitness curves are both biologically meaningful and representative of deeply conserved 
homeostatic constraints on bacterial physiology. 
 
To explore the conserved optimizations of bacterial essential gene expression, we 
examined three functional categories having similar expression-fitness relationships in 
E. coli and B. subtilis. CRISPRi targeting of essential cofactor biosynthesis genes 
(KEGG pathways under “Metabolism of cofactors and vitamins”) did not strongly affect 
fitness in either species after 10 generations (Fig. 3.3 A-B). This observation is 
consistent with the small-colony but non-culturable phenotype of essential cofactor 
biosynthesis gene deletions (Koo et al. 2017) and suggests that these cofactors and/or 
the enzymes producing them are present in excess of what is required for exponential 
growth. This buffer may be required to enable rapid shifts in metabolism in response to 
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changing environmental conditions, similar to what has been proposed for the pentose-
phosphate pathway (Christodoulou et al. 2018).  
 
The robustness of both bacteria to CRISPRi targeting of essential cofactor synthesis 
genes contrasts with the strong, approximately linear effect of targeting genes involved 
in translation (KEGG pathways under “Translation”, Fig. 3.3 C-D). Previous work has 
established a linear relationship between growth rate and the number of ribosomes per 
cell during exponential growth in E. coli, B. subtilis, and other bacteria (Schaechter, 
Maaloe, and Kjeldgaard 1958; Scott et al. 2010; Borkowski et al. 2016). By linearly 
inhibiting ribosomal protein expression, we likely decrease the number of functional 
ribosomes, leading to a corresponding linear decrease in growth rate. Moreover, 
feedback to restore ribosomal protein expression is unlikely because most ribosomal 
proteins are negatively regulated by their excess relative to rRNA (Nomura et al. 1980; 
Scott et al. 2014). Depletion of translation factors has a similarly linear effect on growth 
rate (Fig. 3.12, 3.13), likely due to slowed elongation rate (Dai et al. 2016) as has been 
shown for some translation inhibitors (Scott et al. 2010). The conserved linear 
relationship between the expression of proteins involved in translation and growth rate 
reinforces the universal importance of translational capacity for determining growth rate.  
 
CRISPRi targeting of genes involved in cytoplasmic peptidoglycan precursor synthesis 
(KEGG ko00550) also generated strong phenotypes in both species. However, in 
contrast to the linear expression-fitness relationship of genes involved in translation, 
peptidoglycan synthesis genes exhibited bimodal fitness outcomes that depended on 
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predicted sgRNA activity (Fig. 3.3 E-F). Cells tolerated partial repression of these genes 
without exhibiting a fitness defect, perhaps due to transcriptional feedback and/or an 
excess of enzyme. If expression was sufficiently repressed, these strains lysed (Table 
3.4) as has been described for murA, murG, and mraY inhibition in E. coli (Fransen et 
al. 2017; Mengin-Lecreulx et al. 1991; Zheng et al. 2008) and for murC, murD, and 
murG depletion in B. subtilis (Peters et al. 2016). However, the dearth of intermediate 
fitness outcomes upon repression of peptidoglycan precursor synthesis in both species 
is surprising. It suggests that neither species is able to slow growth rate in response to 
reduced flux through cytoplasmic peptidoglycan precursor synthesis to prevent lysis. It 
has been proposed that bacteria use peptidoglycan precursor concentration to sense 
and balance cellular metabolism and growth (Harris and Theriot 2016). This would be 
incompatible with direct feedback regulation of cytoplasmic peptidoglycan precursor 
synthesis and may explain the sharp transition between growth and lysis. 
 
Given the similarity between the expression-fitness curves of most essential genes in E. 
coli and B. subtilis, we reasoned that homologs with substantially different expression -
fitness curves may illustrate biologically relevant differences between the two 
organisms. We identified 9 homologs as significantly different between the two 
organisms (Table 3.7, FDR < 0.2), most of which encoded enzymes involved in 
peptidoglycan synthesis and maturation. In contrast to the conserved bimodal 
expression-fitness relationships of genes involved in cytoplasmic peptidoglycan 
precursor synthesis just discussed (Fig. 3.4, group 3), CRISPRi targeting of genes 
required for producing either UDP-GlcNAc (Fig. 3.4, group 1) or meso-DAP (Fig. 3.4, 
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group 2) differentially affected fitness in the two species. E. coli was robust to CRISPRi 
targeting of these genes, while B. subtilis was sensitive, lysing when these genes were 
targeted with high activity sgRNAs (Fig. 3.4, Table 3.4, 3.7). The differential effect of 
CRISPRi targeting on these genes could be attributed to buffering of either expression 
or activity in E. coli but not in B. subtilis, perhaps mediated by divergent regulatory 
mechanisms (Rodionov et al. 2003; Barreteau et al. 2008). Differences in the fitness 
effect of DAP pathway knockdowns may also be accounted for by peptidoglycan stem-
peptide recycling through the E. coli enzyme Mpl (J. W. Johnson, Fisher, and 
Mobashery 2013). E. coli was also significantly more tolerant of perturbation of mreBCD 
than B. subtilis (Fig. 3.4, group 4), exhibiting a minimal fitness defect after 10 
generations (but lysis after 15 generations, Table 3.3). This observation is consistent 
with the small effect of CRISPRi targeting of mrdA (the PBP2 associated with MreBCD) 
on fitness in E. coli (Fig. 3.8), and with previous work which found that Enterobacter 
cloacae is also relatively unaffected by mreBCD CRISPRi targeting (Peters et al. 2019). 
It is unclear why E. coli and other Gram-negative bacteria are less affected by mreBCD 
CRISPRi targeting than B. subtilis, however transcriptional buffering through feedback 
may play a role. Alternatively, the substantially higher turgor pressure in B. subtilis 
(Osawa and Erickson 2018) may make it less tolerant of cell wall abnormalities.  
 
Singly mismatched CRISPRi is a universal approach for systematically perturbing 
bacterial gene expression. Leveraging this technique, we explore the expression-fitness 
relationships of essential genes in E. coli and B. subtilis and reveal that the basic 
biological constraints driving essential gene fitness landscapes are conserved over >2 
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billion years of evolution. These studies inform target selection for drug design, 
illuminate aspects of bacterial growth, and provide a starting point for investigating how 
bacteria program robustness into their essential gene network.  
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Figure 3.1 
Singly mismatched sgRNAs reproducibly generate a range of knockdown efficacies in 
B. subtilis and E. coli and are accurately predicted by a simple linear model. (A) 
Workflow of a FACS-seq experiment. (B) FACS-seq scores (average of 2 biological 
replicates) for each singly mismatched sgRNA targeting gfp in B. subtilis and E. coli. 
Additional noise in E. coli likely represents changes in plasmid copy number during 
outgrowth. (C) The predictions of a linear model trained on GC%, mismatch position, 
and mismatch identity compared to the measured relative gfp knockdown efficacies of 
each sgRNA averaged over both species. Inset is a histogram of the differences 
between predicted and measured knockdown, reflecting both prediction and 
measurement error: 56% of sgRNAs measured within 0.15 of their predicted activity 
(red bars). (D) The predictions of the linear model compared to the measured singly 
mismatched sgRNA association rates (kON) in vitro (Boyle et al. 2017). 
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Figure 3.2 
Singly mismatched sgRNAs targeting two essential genes in E. coli and B. subtilis 
illustrate the gene-specific nature of expression-fitness relationships. (A) Schematic of 
the fitness experiment design. (B-E) Predicted sgRNA activity and measured relative 
fitness of singly mismatched sgRNA targeting (B) murAA in B. subtilis. (C) murA in E. 
coli. (D) dfrA in B. subtilis. (E) folA in E. coli. Median and SD values of relative fitness for 
sgRNAs grouped into 17 bins based on predicted knockdown are shown in red. (F) 
Predicted sgRNA activity and relative expression for 18 singly mismatched sgRNA 
targeting a murAA-gfp transcriptional fusion in a murAA–complemented B. subtilis strain 
(Methods). Relative expression is shown as the median single-cell GFP fluorescence, 
normalized as a fraction of control (no sgRNA). (G) Measured relative fitness of singly 
mismatched sgRNAs targeting dfrA in B. subtilis with relative fitness > 0.95 in LB 
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(n=252). Measured fitness values of the same sgRNAs in the presence of sub-inhibitory 
concentrations of trimethoprim. 
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Figure 3.3 
Expression-fitness relationships of essential genes are conserved within biological 
process and between B. subtilis and E. coli. Relative fitness compared to predicted 
knockdown for: essential cofactor biosynthesis genes (KEGG pathways under 
“Metabolism of cofactors and vitamins”) in B. subtilis (A) or E. coli (B); KEGG pathways 
under “Translation” in B. subtilis (C) or E. coli (D); peptidoglycan biosynthesis (KEGG 
pathway ko00550) in B. subtilis. (E) or E. coli (F).  
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Figure 3.4 
Similar and different expression-fitness relationships of cell wall biosynthesis genes in 
B. subtilis and E. coli. (A) Pathway of peptidoglycan synthesis and incorporation, color 
coded by portion of the pathway. (B) Predicted knockdown vs. relative fitness for the 
groups of essential genes from pathway sections indicated in (A), in B. subtilis and E. 
coli. 
Note 3.1 
To facilitate the exploration of essential gene requirements in diverse conditions, we 
also constructed smaller (11 sgRNA/gene) libraries that can be easily manipulated, 
screened, and multiplexed.  These libraries generate a broad range of phenotypes for 
most genes (Fig. 3.14) in B. subtilis and E. coli. 
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Materials and Methods 
Materials 
 
Bacillus subtilis strain construction and growth conditions 
All primers are described in Table 3.8, and all strains are described in Table 3.9. 
All B. subtilis strains were constructed in the wildtype 168 background using natural 
competence as previously described (Koo et al. 2017). For all individual CRISPRi 
strains and libraries, a recipient strain encoding dcas9 under control of the Pxyl 
promoter at the lacA locus (strain CAG74209) (Peters et al. 2016), was transformed 
with an sgRNA plasmid (see “sgRNA plasmid construction”) which recombines in single 
copy at the amyE locus, selecting for chloramphenicol resistance. In select cases, 
single- vs. double-crossover events from plasmid integration were distinguished by 
streaking on starch plates to assay disruption of amyE. 
For the GFP knockdown FACS-seq experiments, two modified recipient strains 
expressing dcas9 were constructed: one encoding gfp (strain CAG78920) and the other 
encoding rfp (strain CAG78921). To construct these, the dcas9 strain (strain 
CAG74209) was transformed with pDG1731-gfp or pDG1731-rfp to integrate Pveg-gfp-
spc or Pveg-rfp-spc, respectively, at the thrC locus, selecting for spectinomycin 
resistance. All subsequent transformations of the gfp and rfp-marked strains required 
threonine supplementation in the competence media (40μg/ml), as thrC is disrupted. 
For flow cytometry-based competition experiments (see “Relative fitness validation”), 
the dcas9 recipient strain was transformed with a modified sgRNA plasmid that also 
encodes either Pveg-gfp or Pveg-rfp (see “sgRNA plasmid construction”). 
A murAA-gfp transcriptional fusion knock-down reporter strain was constructed by 
transformation of the dcas9 strain (above) with the DNA fragments containing 
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constitutively expressed rfp with removable kanR cassette, murAA-gfp transcriptional 
fusion with removable kanR cassette, and constitutively expressed non-targeted murAA 
with spectinomycin resistant gene, of which fragments were integrated into sacA, 
murAA and thrC locus respectively, sequentially in that order. The B. subtilis Pveg 
promoter was used for constitutive expression of rfp and non-targeted murAA. The DNA 
fragment containing constitutively expressed rfp with removable kanR cassette was 
constructed by joining PCR of three fragments: Pveg-rfp-kanR fragment amplified from 
pACYC-rfp-kanR, and 1kb each 5′ and 3′ flanking sequences of sacA. The DNA 
fragment containing murAA-gfp transcriptional fusion with removable kanR cassette was 
constructed by the joining of gfp-kanR amplified from pACYC-gfp-kanR, 1kb of the 3’ 
end of the murAA open reading frame, and 1kb downstream of the murAA open reading 
frame. Before the gfp-kanR fragment was integrated downstream of murAA to generate 
strain CAG78923, the kanR cassette was removed from rfp strain as described 
previously to generate strain CAG78922 (Koo et al. 2017). Non-targeted murAA was 
designed to remove PAM sequence or alter the sgRNA targeting sequence without 
substituting amino acid sequence of murAA. Non-targeted murAA DNA was generated 
by overlapping PCR with mutagenic primers (Table 3.8) and its BsiWI/NruI digested 
fragment were cloned into pJMP3 (Addgene #79875) digested with BsrGI/PmeI. The 
cloned plasmid was transformed into the dcas9, rfp, murAA-gfp strain, selecting for 
spectinomycin resistance, to generate strain CAG78924. Finally, this strain was 
transformed with sgRNA plasmids as described above. 
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Unless otherwise noted, all strain construction and growth assays for B. subtilis were 
done in LB medium and using antibiotics at the specified concentrations: erythromycin 
(1μg/ml), spectinomycin (100μg/ml), chloramphenicol (7.5μg/ml), kanamycin (7.5μg/ml). 
 
Escherichia coli strain construction and growth conditions 
All CRISPRi library strains were constructed in the wildtype BW25113 background by 
electroporating an sgRNA plasmid or plasmid pool (see “sgRNA plasmid construction”) 
into a recipient strain encoding dcas9 (for essential gene knockdown libraries), or dcas9 
and gfp or rfp (for GFP knockdown libraries), selecting for ampicillin resistance. 
For the essential gene knockdown library recipient strain (strain CAG78830), Tn7 
transposition was used to integrate a dcas9 expression cassette into the Tn7att site 
using triparental mating of DAP(diaminopimelic acid)-dependent donors and selecting 
for gentamicin resistance in the absence of DAP, as previously described (Peters et al. 
2019). The dcas9 expression cassette is modified from previously described versions 
(Peters et al. 2019), contains dcas9 from S. pyogenes (Qi et al. 2013)with a 3X Myc C-
terminal tag, and is expressed from the IPTG-inducible promoter PlLac-O1 (Lutz and 
Bujard 1997) and regulated by lacIq. 
For the GFP knockdown FACS-seq experiments, two recipient strains expressing dcas9 
were constructed: one encoding gfp (strain CAG78108) and the other encoding rfp 
(strain CAG78107). Each was generated by first cloning the constitutive gfp and rfp 
expression cassettes from pDG1731-gfp and pDG1731-rfp upstream of frt-cat-frt from 
pKD3 (Datsenko and Wanner 2000), integrating them into the chromosome between 
yjaA and yjaB using recombineering (Thomason et al. 2014), and selecting for 
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chloramphenicol resistance. P1 transduction (Thomason, Costantino, and Court 2007) 
was then used to move the gfp-frt-cat-frt or rfp-frt-cat-frt cassettes into BW25113, 
selecting for chloramphenicol resistance. Chromosomal dcas9 was then introduced to 
these strains by conjugation using a pseudo-Hfr dcas9 donor, as described previously 
(Rauch et al. 2017), where in this case the dcas9 is expressed by the minimal synthetic 
promoter PBBa_J23105 {https://parts.igem.org}, and transconjugates were selected 
using gentamicin and chloramphenicol. 
Unless otherwise noted, all strain construction and growth assays for E. coli were done 
in LB medium and using antibiotic selection at the specified concentrations: ampicillin 
(100μg/ml), carbenicillin (50μg/ml), gentamicin (10μg/ml), chloramphenicol (25μg/ml). 
 
Bacillus subtilis CRISPRi library construction 
As in the individual CRISPRi strain construction (above), CRISPRi libraries were 
constructed by transforming sgRNA plasmids into the dcas9 strain. The protocol was 
modified in one of two ways in order to increase the scale; we found both methods were 
sufficient to maintain coverage of the pooled plasmids. In one method, cells were grown 
in B. subtilis competence medium to OD600=1.5, and then incubated with plasmid DNA 
(300μl cells + 300ng plasmid DNA) in 96-well deep-well plates. Incubations were 
performed for 2hr at 37C with shaking (900RPM), after which point plates were spun 
down at 5000g for 10 minutes and resuspended in 2mL LB medium before plating on 
plates (Falcon #351058) with chloramphenicol at a density ~0.4M CFU/plate and growth 
overnight at 37C. A second method incubated competent cells (grown in B. subtilis 
competence medium to OD600=1.5) with plasmid DNA in culture flasks, for 2hr at 37C 
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with shaking (900RPM), after which point cells were spun down in 50ml tubes and 
resuspended in 2-6ml LB before plating on chloramphenicol plates as before. 
To store the transformed CRISPRi library, plates were scraped, pelleted and 
resuspended in S7 salts (Koo et al. 2017) with 15% glycerol, and stored in 500uL 
aliquots at -80C. 
 
Escherichia coli CRISPRi library construction 
Strain library construction from plasmid libraries was achieved by electroporating 
plasmid DNA into the recipient strains, and plating on plates (Falcon #351058) with 
carbenicillin and 0.2% glucose (to repress uptake of residual lactose in LB that can 
induce the IPTG-controlled dcas9 in the essential gene knockdown strains) at a density 
~0.4M CFU/plate and growth overnight at 37C. To store the libraries, plates were 
scraped, pelleted, and resuspended in 15% glycerol to be stored at -80C. 
 
sgRNA plasmid construction 
The sgRNA plasmid pJSHA77 was modified from pDG1622 to increase transformation 
and double-crossover efficiency. 1.5kb of DNA upstream of amyE was PCR amplified 
from B. subtilis 168 genomic DNA and inserted into pDG1662 by HiFi Assembly (New 
England Biolabs #E2621L), replacing the shorter upstream fragment of amyE in 
pDG1662. Synthetic DNA containing a transcription terminator, an sgRNA driven by 
Pveg with BsaI cut sites for spacer cloning, and downstream tandem transcription 
terminators was purchased from IDT and cloned into the previously described pDG1662 
derivative by HiFi Assembly (New England Biolabs #E2621L), generating pJSHa77. 
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Oligonucleotide pools containing the desired elements with flanking restriction sites and 
library-specific PCR adapters were obtained from Agilent Technologies (Table 3.8). The 
oligonucleotide pools were amplified by 15 cycles of PCR using Q5 polymerase (New 
England Biolabs #M0493S) and custom primers (Table 3.8). The PCR product was 
digested with BsaI-HFv2 (New England Biolabs #R3733) and gel purified from 10% TBE 
gels (Invitrogen #EC6275BOX) to remove adapter ends. pJSHA77 vector was midi-
prepped (Qiagen #12143), digested with BsaI-HFv2 for 1hr, and treated with Antarctic 
phosphatase (New England Biolabs # M0289S), and ligation was carried out at a 1:2 
(vector:insert) molar ratio using T4 DNA Ligase (New England Biolabs #M0202L). 
Ligations were transformed into electrocompetent cells (New England Biolabs 
#C3020K), recovered for 1hr at 37C in LB, and then inoculated into 100ml with 
carbenicillin and grown overnight. Plasmid libraries were collected by midiprep (Qiagen 
#12143) and analyzed by deep sequencing (Illumina MiSeq #MS-103-1002) to assess 
cloning efficiency and library diversity.  
For individual sgRNA strains, inserts were prepared by annealing two single-stranded 
DNA oligos together to create the 4-base overhangs, and then annealed inserts were 
ligated using T4 DNA Ligase (New England Biolabs #M0202L) individually into 
pJSHA77 digested with BsaI-HFv2 and treated with Antarctic phosphatase (New 
England Biolabs # M0289S). 
For the single-strain competition validation strains, pJSHA77 was first modified to 
incorporate a constitutively expressed Pveg-gfp or Pveg-rfp using HiFi Assembly (New 
England Biolabs #E2621L). Strains were then constructed as described above, ligating 
annealed-pair inserts into the modified vector after digesting with BsaI-HFv2. 
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sgRNA plasmid library design  
Code for designing (fully matched) sgRNA spacers targeting a list of genomic loci can 
be found at https://github.com/traeki/sgrna_design.  
Non-targeting sgRNA controls were designed by creating random 20nt sequences with 
a distribution of GC content similar to B. subtilis (~45%), and then using bowtie 
(Langmead et al. 2009) to identify (and subsequently filter out) sgRNAs which aligned 
(allowing 3 or fewer mismatches) to other intragenic targets in the combined genomes 
of E. coli and B. subtilis, or any targets in gfp or rfp. 
For the libraries targeting all essential genes in B. subtilis, multiple iterations of sgRNA 
library design (i.e. spacer design), construction, and analysis were used. For B. subtilis 
libraries, all presented data is from V2 library measurements, with the exception of the 
trimethoprim experiments which used measurements of the V1 libraries (all data in 
Table 3.3). 
For the V1 libraries targeting B. subtilis genes we chose target genes to be all those 
previously identified as essential, putative essential, or low-fitness (Koo et al. 2017; 
Peters et al. 2016) (Table 3.3). For every gene in the V1 set, two non-overlapping fully 
complementary spacers were chosen, each targeting the non-template strand as close 
to the start of the ORF as possible. For each fully complementary spacer, a set of 25 
spacer variants were designed and ordered: 2x the fully complementary spacer, 5x 
randomly chosen single-mismatches within 7 bases of the PAM, 5x randomly chosen 
single-mismatches 8-12 bases from the PAM, 3x randomly chosen single-mismatches 
13-19 bases from the PAM (to exclude the outermost base), 10x randomly chosen 
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double mismatches 1-19 bases from the PAM. In addition, for every gene the first three 
non-overlapping template-strand spacers were included. 
The V2 B. subtilis libraries included all essential B. subtilis genes as well as a subset of 
non-essential but fitness-impacting genes (Table 3.3) from V1 of the library. The V2 E. 
coli libraries included a majority of genes with evidence for essentiality (Table 3.3) (Koo 
et al. 2017). For every gene in this set, ten non-overlapping fully complementary 
spacers were chosen on the non-template strand, as close to the start of the ORF as 
possible. For each fully complementary spacer, a set of 10 spacer variants was 
designed and ordered (for a total of 100 sgRNAs per gene): 1x the original fully 
complementary spacer, 9x single-mismatches (Fig. 3.5). Single-mismatches were 
chosen using the following criteria: all possible single-mismatch variants were evaluated 
by the trained linear model for a predicted sgRNA activity 
{https://github.com/traeki/mismatch_crispri, train_linear_model.py and 
choose_guides.py}. These predicted sgRNA activities were categorized into five bins: 
<10%, >90%, and three equally sized bins between 10% and 90% predicted sgRNA 
activity. Three sgRNAs were chosen from each of the middle three bins.     For the 
design of all libraries using this strategy, a preliminary version of the linear model was 
used. 
The compact libraries with 11 sgRNAs per gene were selected as above, with the 
following modifications for both species: for each gene 2x fully complementary sgRNAs 
were chosen, and 9x single-mismatch variants were selected from among all possible 
single-mismatch variants of each, using a binning strategy as described above (Fig. 
3.5). For E. coli, also as described above, the bins were generated using predicted 
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sgRNA activity. For B. subtilis the bins were instead generated using the measured 
relative fitness values from the V1 experiment, and the selected sgRNAs were therefore 
a subset of those used in the V1 library. 
The dfrA, gfp, and rfp V1 comprehensive libraries (used in the trimethoprim experiment 
and all FACS-seq experiments) were designed analogous to the V1 essential gene 
libraries, with 100 sgRNAs per target: 4x the original fully complementary spacer, 20x 
randomly chosen single-mismatches within 7 bases of the PAM, 15x randomly chosen 
single-mismatches 8-12 bases from the PAM, 12x randomly chosen single-mismatches 
13-20 bases from the PAM, and 49x randomly chosen double mismatches 1-20 bases 
from the PAM (Fig. 3.5). 
For the V2 comprehensive libraries targeting dfrA, murAA, folA, or murA, we designed 
all possible non-template spacers, each with all possible single-mismatches, for a total 
of 60x mismatch variants per fully complementary sgRNA. 
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Methods 
Relative fitness experimental details 
Glycerol stocks of the B. subtilis essential-gene library (V1 or V2), the dfrA and murAA 
libraries (V1 or V2), and the library of non-targeting control sgRNAs were fully thawed, 
mixed,  and inoculated into 150 mL cultures of LB at a combined OD600 of 0.01 (5% 
control, 75% essential-gene library, 10% dfrA library, 10% murAA library). This culture 
was allowed to grow to OD600 0.1, at which point the culture was back-diluted to 
OD600 0.01 in fresh 150 mL culture of LB + 1% xylose. This culture was then grown to 
OD600 0.3 (~5 doublings), back-diluted to OD600 0.01 in LB + 1% xylose, and grown to 
OD600 0.3 (total ~10 doublings). Samples were collected a) immediately before back 
dilution into xylose and b) after the final growth phase, ~10 doublings apart (Fig. 3.6 A). 
The trimethoprim experiments were carried out in an identical manner, except that both 
1% xylose and trimethoprim (0 ng/mL, 15ng/mL, or 30ng/mL) were added from the first 
back-dilution and maintained throughout growth. Concentrations of trimethoprim were 
chosen such that wildtype growth rate was unaffected. 
Fitness experiments for the E. coli V2 libraries were carried out in an identical manner to 
the B. subtilis fitness experiments with the following exceptions: all growth occurred in 
the presence of ampicillin, and induction was achieved with 1mM IPTG instead of 1% 
xylose. 
For both B. subtilis and E. coli, compact library experiments were carried out in an 
identical manner as the larger scale fitness experiments above, save that the volume of 
cultures was 15mL, and only compact libraries and non-targeting control libraries were 
mixed together (90% compact library, 10% controls). 
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At the desired time points, B. subtilis cultures were collected (1ml) by pelleting (9000xg 
2min) and genomic DNA was extracted using the DNeasy Blood & Tissue kit (Qiagen 
#69506) with the recommended Gram-positive pre-treatment and RNAse A treatment. 
For the E. coli fitness experiments, E. coli cultures were collected (4ml) by pelleting 
(20000xg 2min) and plasmid DNA was extracted using the QIAprep Spin miniprep kit 
(Qiagen #27106). sgRNA spacer sequences were amplified from gDNA or plasmid DNA 
using Q5 polymerase (New England Biolabs #M0493S) for 14x cycles using custom 
primers containing TruSeq adapters and indices (Table 3.8), followed by gel-purification 
from 8% TBE gels (Invitrogen #EC62152BOX), and sequencing on HiSeq 4000 with 
single-end 50bp reads using a custom sequencing primer (UCSF Center for Advanced 
Technology). 
 
Relative fitness analysis 
Raw FASTQ files were aligned to the library oligos and counted using { 
https://github.com/traeki/mismatch_crispri, count_guides.py}, and relative fitness was 
calculated using {https://github.com/traeki/mismatch_crispri, compute_gammas.py and 
gamma_to_relfit.py}. For each strain (x) with at least 100 counts at t0 we calculate the 
relative fitness F(x) according to: 
 
𝐹(𝑥) = 	 𝑙𝑜𝑔2	 𝑟,-(𝑡/) ∗ 𝑟1(𝑡2/)𝑟,-(𝑡2/) ∗ 𝑟1(𝑡/)	𝑔,- + 1 
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where rx(ti) is the fraction of strain X in the population at time i and gwt is the number of 
generations of wildtype growth in the experiment. A derivation of this equation can be 
found in (Keren et al. 2016) and (Rest et al. 2013). In our experiments, gwt is calculated 
from the OD measurements of the culture, and rwt(ti) is calculated as the median of 1000 
non-targeting control sgRNAs from that sample. For strains with at least 100 counts at t0 
and 0 counts at t10, we set: 
 
𝑙𝑜𝑔2	 𝑟1(𝑡2/)𝑟1(𝑡/) = 0 
 
Finally, the relative fitness measurements of each sgRNA were averaged across 
samples (B. subtilis experiments: 6 replicates, E. coli experiments: 4 replicates) to 
calculate the final relative fitness value and standard deviation (Table 3.3). 
 
Relative fitness validation 
To validate the practice of using pooled growth measurements as an approximation of 
relative fitness, we also measured the relative fitness of individual dfrA knockdown 
strains grown in the presence of a wildtype strain. For each dfrA sgRNA, the spacer was 
cloned separately into pJSHA77-gfp and pJSHA77-rfp, each transformed into the dcas9 
strain, and then competed against a wildtype constitutively expressing the opposite 
fluorophore (i.e. strains with a dfrA sgRNA and expressing gfp were competed against a 
wildtype expressing rfp). Strains were mixed at a starting OD600 of 0.01 in 300μL of LB 
in four replicate wells of a 96-well deep-well plate, covered with a breathable film, and 
grown shaking at 900 RPM at 37C. Cells were diluted to OD600 0.01 in fresh LB with 
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1% xylose and grown again (900 RPM, 37C) to OD600 0.3. Immediately after each 
back-dilution (and at end of experiment) the previous plate was fixed with 50μL of 37% 
formaldehyde per well, incubated for 10min at room temperature, and quenched with 
50μL of 2.5 M glycine. The quenched reaction was diluted 1:20 into 1X PBS before 
measurement by flow cytometry (LSRII, BD Biosciences) using the blue laser (488 nm) 
and the FITC detector (530/30 nm) for GFP detection, and the yellow/green laser (561 
nm) and the PE-Texas Red detector (610/20 nm) for RFP detection. Data for at least 
20,000 cells were collected, and thresholds based on control wells were used to define 
the GFP+ and RFP+ populations to determine the ratio of each population in each 
sample using FlowJo (FlowJo, LLC). All calculated relative fitness measurements from 
this validation experiment are provided in Table 3.3. 
 
FACS-seq experimental details 
Three separate strain libraries were constructed and mixed together for use in the 
sorting experiments: a gfp+ strain with the gfp-targeting sgRNA library (mismatch-GFP), 
a gfp+ strain with the non-targeting sgRNA control library (“high-GFP” or “control 
sgRNA” in figure), and a gfp- strain with the rfp-targeting sgRNA library (“no-GFP” or 
“dark control”) (Fig. 3.5 A). Glycerol stocks of each library were fully thawed, inoculated 
into replicate 12.5ml cultures of LB (B. subtilis) or LB with ampicillin (E. coli) at 0.01 
OD600, and allowed to grow for 2.5-3hr. Then cultures were back-diluted to 0.01 
OD600 in LB with 1% xylose (B. subtilis) or LB with ampicillin (E. coli) and grown for 
2.5hr. Immediately before sorting the cultures were mixed at a ratio reflecting the overall 
diversities of their libraries (40% mismatch-GFP, 40% low-GFP, 20% high-GFP), and 
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then the mixture was diluted 1:10 in PBS at room temperature (B. subtilis) or on ice (E. 
coli).  
Sorting was done on the mixed cultures using a BD FACSAria II (Laboratory for Cell 
Analysis in Helen Diller Family Comprehensive Cancer Center at UCSF), using the blue 
laser (488 nm) and the FITC detector (530/30 nm), and at a flow rate of 5 and collecting 
for 20min total. Post-sorting the collected bins were filtered using either cellulose nitrate 
membranes with 0.2um pore (Thermo Scientific #145-0020) or mixed cellulose esters 
0.22um pore disc filters (MF-Millipore #GSWP02500) on a glass filtration apparatus. 
Filters were resuspended in 9ml LB (B. subtilis) or LB with ampicillin (E. coli) by 
vortexing at max speed for 30s, then split into two outgrowth cultures and grown 
overnight in 4ml LB (B. subtilis) or LB with ampicillin (E. coli). A portion of the input 
mixed sample (i.e. pre-sorting) was treated similarly and grown overnight. DNA was 
extracted from each outgrowth culture separately and analyzed by deep sequencing as 
described above. 
 
FACS-seq analysis 
For each species, two biological replicates (i.e. cultures starting from unique glycerol 
stocks) were sorted by FACS, and from each biological replicate’s 4 bins (plus unsorted 
mixture) two technical replicates (i.e. two overnight outgrowth cultures from which DNA 
was extracted) were sequenced. Library spacers were counted in each sequenced 
sample, normalized to the sample’s total number of spacers counted, and technical 
replicate normalized counts were added together. For each biological replicate, the 
sorted bins were further normalized with respect to the mixed (i.e. pre-sorting) sample in 
 94 
the following manner: a linear model was used to determine the appropriate weights for 
each bin in order to recapitulate the mixed sample, and those weights were applied as 
scaling factors for all read counts from the given bin. This normalization was essential to 
correct for sequencing depth and cell number differences between bins. Briefly, we 
used the sklearn package (sklearn.linear_model) in Python and applied it to the mixed 
sample after removing from it the top and bottom 5th percentiles.  
We sought to define a metric for enrichment in the GFP-high bins vs. the GFP-low bins 
that would be similar in scale to relative fitness. We define an enrichment ratio (ER) for 
each sgRNA as: 
 
𝐸𝑅 = 33𝑛. 𝑛𝑜𝑟𝑚<=>? +	23 ∗	𝑛. 𝑛𝑜𝑟𝑚<=>@ 	13 ∗ 	𝑛. 𝑛𝑜𝑟𝑚<=>A + 03 ∗ 	𝑛. 𝑛𝑜𝑟𝑚<=>2 
 
where n.normBin i is the normalized counts in Bin i, and Bin1 has the lowest GFP 
fluorescence while Bin4 has the highest. By this metric, values close to 1 have the 
highest GFP fluorescence (or weakest sgRNA activity) and values <1 have lower GFP 
fluorescence (or stronger sgRNA activity). Enrichment scores were normalized on a per 
experiment basis by subtracting the mean enrichment score of the “dark controls” and 
dividing by the mean enrichment score of the “high-GFP” strains. The resulting scores 
for each sgRNA (called the “FACS-seq score” in the main text) are available in Table 
3.1. 
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FACS-seq validation 
To validate our sorting procedure and the relationship between the calculated FACS-
seq score and the fluorescence of a single strain, we randomly isolated 9 strains from 
the E. coli GFP knockdown library and analyzed them by flow cytometry to quantify 
knockdown relative to a non-targeting sgRNA (Fig. 3.6 E-H). Strains were grown in 
deep 96-well plates in 300ul LB overnight, diluted back and grown to ~0.4 OD600 
before measurement. Briefly, data was collected on a LSRII flow cytometer (BD 
Biosciences) using the blue laser (488 nm) and the FITC detector (530/30 nm). Data for 
at least 20,000 cells were collected, and median fluorescence values were extracted 
using FlowJo (FlowJo, LLC). Data from representative samples were plotted as 
histograms using FlowJo to confirm that single-cell fluorescence was unimodal within 
the population (Fig. 3.6 E-H). sgRNA plasmids were miniprepped (Qiagen #27106) from 
each library isolate and Sanger sequenced to ascertain their identity in the library 
experiment. To assay the behavior of the same sgRNAs in B. subtilis, the miniprepped 
plasmid was transformed into B. subtilis as described above, double-crossover events 
were verified by streaking on starch plates, and the strains were analyzed by flow 
cytometry as described above. All relative fluorescence measurements are provided in 
Table 3.1 and plotted in Fig. 3.6 A. 
 
Predicted sgRNA activity validation 
To validate the linear model’s ability to predict sgRNA activity based on sgRNA 
sequence, we measured the knockdown of a murAA-gfp transcriptional fusion in a B. 
subtilis strain that was complemented by a non-targeted copy of murAA. These strains 
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also expressed a chromosomal rfp that allowed for calculation of the GFP/RFP ratio on 
a per cell basis. Strains were grown as described above (FACS-seq validation), with the 
exception that dcas9 was induced using 1% xylose after dilution. Data was collected on 
a LSRII flow cytometer (BD Biosciences) using the blue laser (488 nm) and the FITC 
detector (530/30 nm) for GFP detection, and the yellow/green laser (561 nm) and the 
PE-Texas Red detector (610/20 nm) for RFP detection. Data for at least 20,000 cells 
were collected, and the per-cell GFP/RFP ratios as well as the population median 
GFP/RFP ratios were extracted using FlowJo (FlowJo, LLC). Relative knockdown was 
normalized to a murAA-gfp strain lacking a sgRNA, after first subtracting the 
background GFP fluorescence from a non-fluorescent B. subtilis strain. Relative GFP 
fluorescence measurements are provided in Table 3.10. 
 
Linear model of singly mismatched sgRNA efficacy 
Having measured the ability of ~1,600 singly mismatched sgRNAs to knockdown GFP 
expression, we sought to build a model to predict the effect of mismatches on sgRNA 
efficacy. Since an enrichment score of 1 represent maximal GFP fluorescence, and a 
score of 0 represents no GFP fluorescence, we define knockdown for each sgRNA as: 
 𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛FGHIJ = 1 − 𝐹𝐴𝐶𝑆. 𝑠𝑒𝑞	𝑠𝑐𝑜𝑟𝑒	 
 
We then normalized the ability of each mismatched sgRNA to knockdown GFP 
compared to its equivalent fully complementary sgRNA using the equation below: 
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𝑠𝑔𝑅𝑁𝐴	𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦F=>GWX	Y=FYZ-[\]^	FGHIJ = 	 𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛	F=>GWX	Y=FYZ-[\]^	FGHIJ𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛	_`WWX	[aYbW]Y]>-ZcX	FGHIJ	 
 
We next built a model that fit the activity of each sgRNA using the position of the 
mismatch (from 0 to 19, with 19 being PAM proximal, one hot encoded), the transition of 
the mismatch (from X to Y, one hot encoded), and the GC% of the fully complementary 
sgRNA. Mismatched sgRNAs were excluded from the analysis if they were variants of 
fully complementary sgRNAs with less than 0.5 knockdown (as described above). The 
parameters from this model trained on  E. coli, B. subtilis, or species-averaged per 
sgRNA activity are presented in Table 3.2 and Fig. 3.14, the raw data in Table 3.1. 
 
Expression-fitness relationship analysis 
In order to quantitatively assess the expression-fitness relationship of genes targeted by 
the V2 E. coli and B. subtilis libraries, we developed a per gene pipeline, described 
below.  
 
1. In general, fully complementary sgRNAs targeting the same gene had similar 
fitness effects (Fig. 3.15 and supplementary text 1), suggesting that all fully 
complementary sgRNAs induce a similar level of knockdown. We identified outlier 
sgRNAs that were significantly less effective at inducing a fitness defect (and therefore 
were likely to be ineffective at knocking down their target) by comparing the distribution 
of fitness values for each series (series = the fully complementary sgRNA and its 9 
singly mismatched variants) to the fitness distribution of the remaining series targeting 
the same gene. Using a two-sided t-test, we assessed whether the distribution of their 
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relative fitness values was significantly different (p < 0.05) from the relative fitness 
distribution of the remaining sgRNAs targeting the gene. If their distribution was 
significantly different and their mean relative fitness was higher than the other sgRNAs 
targeting the same gene, we surmised that the fully matched sgRNA was likely not 
functional and excluded its series from further analysis.  
 
2. We next predicted the sgRNA activity of all sgRNAs using the model of sgRNA 
efficacy described above trained on the two species averaged GFP data also described 
above. Consistent with the definition of sgRNA activity above, fully complementary 
sgRNAs were assigned a sgRNA activity of 1.  
 
3. We binned sgRNAs that passed our filter (Step 1) based on their predicted 
sgRNA activity (bin width = 0.2, bin spacing = 0.05, for a total of 17 bins), and within 
each bin we calculated the median relative fitness. A fully healthy (relative fitness = 1, 
predicted sgRNA activity = 0) pseudocount was included for each gene. Per sgRNA and 
per gene patterns are shown in Fig. 3.12 (E. coli) and Fig. 3.13 (B. subtilis). Per gene 
bin medians for essential genes can be found in Table 3.5.  
 
Per gene bin medians were used in all analyses of gene expression-fitness relationship 
similarity.  
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Gene expression-fitness relationship clustering and enrichment analysis 
To determine whether per gene expression-fitness curves were biologically meaningful, 
we clustered the bin medians (described above) for all essential gene in E. coli and B. 
subtilis into 9 clusters using k-means with 10,000 random restarts. Functional 
enrichment within clusters was calculated for COG categories, GO biological process 
terms, and KEGG terms using the hypergeometric test. Only p-values with Bonferroni 
corrected (p < 0.05) are shown in Table 3.6.   
 
Gene similarity comparisons 
To determine whether the expression-fitness relationships of genes within COG 
categories, GO biological process, or KEGG categories were more similar to each other 
than to those of other genes we first calculated pairwise Euclidean distances between 
the expression-fitness relationships of all essential genes within each species. We then 
used a two-sided t-test to compare the distances between genes within each category 
to the distances between those genes and genes in different categories. We accounted 
for CRISPRi polarity due to operon structure by excluding any distances between genes 
within the same operon (defined as two genes in the same direction <50bp apart) from 
both the “inside category” and the “outside category” set. 
To determine whether the expression-fitness relationships of homologous genes were 
more similar to each other than to those of other genes in the opposing organism, we 
calculated the pairwise Euclidean distance between the expression-fitness relationships 
of all essential genes that have essential homologs in both E. coli and B. subtilis (n = 
155, as defined in Koo et at., 2017). We next used a two-sided t-test to determine if the 
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distance between homologs was, on average, different from the overall distribution of 
distances between these 155 genes (i.e. when one gene from one species is compared 
to the 154 genes in the opposing species). To determine which pairs of homologs were 
significantly dissimilar, for each gene pair (including homologs), we calculated how 
many cross-species comparisons involving either gene were more similar than the 
comparison in question. We compared this number in homologs and non-homologs to 
calculate a FDR.  
 101 
Supplementary Text 
1. Quantifying similarity between fully complementary guides targeting the same gene 
Our gfp based model predicts the activity of singly mismatched sgRNAs relative to the 
activity of the fully complementary sgRNA from which they are derived. To use this 
relative sgRNA activity as a proxy for absolute activity, fully complementary sgRNAs 
targeting the same gene should have the same activity. Since we cannot easily 
measure the sgRNA activity directly when targeting endogenous essential genes, we 
reasoned that we could validate this assumption by comparing fitness effect of fully 
complementary sgRNAs targeting the same gene. To do so, we compared the total sum 
of squares (totalSS) of fully complementary sgRNAs to within gene the sum of squares 
(withinSS). In E. coli, the withinSS accounted for 26.7% of the totalSS and in B. subtilis 
the withinSS accounted for 18.6% of the totals. This suggests that fully complementary 
sgRNAs targeting the same gene are substantially more similar with regards to their 
fitness outcomes than fully complementary sgRNAs as a whole, and supports the 
assumption that fully complementary sgRNAs targeting the same gene have similar 
levels of activity. 
 
2. Detection limits of relative fitness measurements 
Our relative fitness experiments seek to quantify the number of doublings each strain 
experiences during the course of the experiment, relative to the number of doublings a 
wild-type (or a non-targeting sgRNA control) strain experiences during this time. To do 
so, we measure the bulk growth of the population, and quantify the relative abundance 
of each strain at the start and end of each experiment via next-generation sequencing. 
Changes in the relative abundance of a strain are determined by the growth rate of the 
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individual strain relative to the population as a hole. For example, there is a 210 ~ 1,000-
fold increase in the number of cells during a 10 doubling experiment. Therefore, cells 
that do not divide (but remain intact) will experience a 1,000-fold decrease in relative 
abundance.  
 
Our ability to measure the relative abundance of strains is constrained by sequencing 
depth.  Assuming an equal number of reads at the start and end of the experiment, 
measurement of a 1,000 fold decrease in relative abundance requires that a strain have 
at least 1,000 reads at the start of the experiment. A poorly represented strain (e.g. 50 
read counts at the start of the experiment) cannot decrease 1,000-fold and be 
meaningfully measured.  
 
Previously reported pooled fitness experiments of CRISPRi libraries in E. coli prioritized 
sensitivity to slight growth defects over quantifying the extent of a strong fitness defect 
(Fig. 3.10 D-E). To do so, these experiments were run for many generations (15+) and 
were sequenced with relatively less depth (median counts ~100). This limited their 
ability to quantify strong fitness effects. In contrast, this study prioritized quantification of 
the full range of possible fitness outcomes. As a result, our experiments were run for 10 
generations and deeply sequenced (median counts > 1,000), allowing us to quantify a 
broad range of fitness defects. 
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Many strains were abundant enough at the start of the experiment to allow accurate 
quantification of decreases greater than 210 ~ 1,000-fold. These events (relative fitness 
< 0) represent active depletion from the pool. 
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Figure 3.5 
Design of mismatched sgRNA libraries targeting (A) gfp, (B) comprehensive libraries 
targeting dfrA, folA, murAA, and murA, and (C) each essential gene for the large 
libraries and the compact libraries. The breakdown of single mismatch variants per 
series and the total unique sgRNAs per gene are shown for each. 
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Figure 3.6 
Details related to the linear model, FACS-seq data, and its validation. (A) Mismatched 
sgRNA efficacy measured individually (relative GFP fluorescence) in either E. coli or B. 
subtilis compared to their FACS-seq score from measurements done in the same 
species. Relative fluorescence is the median GFP single-cell fluorescence, normalized 
as a fraction of non-targeted control. (B) FACS-seq scores for all sgRNAs comparing 
two biological replicates in B. subtilis. (C) FACS-seq scores for all sgRNAs comparing 
two biological replicates in E. coli. Increased noise in E. coli likely reflects variation in 
sgRNA plasmid copy number at the time of DNA extraction and/or sequence-based E. 
coli specific effects on sgRNA efficacy (Cui et al. 2018). (D) Coefficients of each 
variable from linear models trained on FACS-seq data from either E. coli or B. subtilis. 
The A to G transition discussed in the main text is highlighted. y_int is the y-intercept; 
GC is the GC% of the fully complementary sgRNA spacer. (E) Schematic describing the 
isolation of random singly mismatched sgRNA strains from the E. coli gfp library, their 
analysis by flow cytometry, the introduction of the same sgRNA plasmids into B. subtilis, 
and their analysis by flow cytometry. (F-G) The distribution of single-cell GFP 
fluorescence values for strains of E. coli (G) or B. subtilis (F). (H) The sequences of the 
spacers indicated in (F) and (G), with mismatched bases highlighted in red. 
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Figure 3.7 
Doubly mismatched sgRNAs are accurately predicted as the combined independent 
effects of singly mismatched sgRNAs. (A) FACS-seq enrichment scores (average of 2 
biological replicates) for each doubly mismatched sgRNA targeting gfp in B. subtilis and 
E. coli.  (B) The predictions of the linear model for doubly mismatched sgRNA efficacy, 
treating each mismatch as independently affecting sgRNA efficacy, compared to the 
doubly mismatched sgRNAs’ measured gfp knockdown efficacies (two species 
averages). (C) The predictions of the linear model for doubly mismatched sgRNAs 
compared to the measured doubly mismatched sgRNA association rates (kON) in vitro 
(14). 
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Figure 3.8 
Linear models of singly mismatched sgRNA efficacy trained on FACS-seq or relative 
fitness data from E. coli, B. subtilis, or the average of both (averaged gfp) retain a 
majority of their predictive power on other singly mismatched sgRNA datasets. Each 
panel compares the predictions of a linear model trained on the specified dataset to the 
measured efficacy (relative fitness or FACS-seq score) of sgRNAs in the other specified 
dataset, with the pearson correlation coefficient shown in the inset. The datasets used 
and evaluated are, in order from top-bottom and left-to-right: species averaged gfp, E. 
coli gfp, B. subtilis gfp, E. coli folA, and B. subtilis dfrA.  
 108 
 
 
Figure 3.9 
Parameters of linear models of singly mismatched sgRNA efficacy trained on FACS-seq 
or relative fitness data from either E. coli or B. subtilis have strongly correlated 
coefficient values. Each panel compares the coefficient values from the linear models 
trained on the two specified datasets.  
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Figure 3.10 
Relative fitness measurements are reproducible, orthogonally validated, and capture a 
large dynamic range. (A-B) Relative fitness measurements from two biological 
replicates in E. coli (A), and B. subtilis (B). (C) Relative fitness from pooled experiment 
compared to a relative fitness metric from competing individual dfrA-targetomg CRISPRi 
strains against a fluorescently labeled wildtype and enumerating their relative 
abundance by flow cytometry before and after 10 doublings. (D & E) Per sgRNA relative 
fitness compared to previously reported fitness measurements (19) and (18) showing 
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the increased dynamic range of our measurements. The minimum quantifiable relative 
fitness can be approximated by the log2(median per sgRNA read count) divided by 
number of generations of growth. In (18), median read count per sgRNA was ~100, and 
strains were grown for ~15 generations; therefore, relative fitness below ~0.6 is not 
resolvable. Similarly, in (19), median read count per sgRNA was >200 (~17 million total 
counts, 92,919 elements), and strains were grown for ~17 generations; therefore, 
relative fitness below 0.6 is not resolvable. See Supplementary Text 2 for further 
discussion. 
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Figure 3.11 
Singly mismatched sgRNAs targeting essential genes are strongly and negatively 
correlated within sgRNA series and within genes. (A-B) Distribution of per sgRNA series 
correlations (r) for sgRNAs targeting genes in E. coli (A) and B. subtilis (B). (C-D) 
Distribution of per gene correlations (r) for sgRNAs targeting genes in E. coli (C) and B. 
subtilis (D). 
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Figure 3.12. All E. coli per gene knockdown-fitness curves 
[INCLUDED AS A SEPARATE FILE] 
 
Figure 3.13. All B. subtilis per gene knockdown-fitness curves 
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Appendix #1 
Validation 
To validate our pooled-growth fitness measurements, we assessed the growth rate of 
individual strains and compared it to the measured growth rate in the pooled 
experiment. We chose 20 of the dfrA sgRNAs exhibiting a diverse set of fitness 
outcomes for individual testing. Each experimental strain was constructed by 
transforming the appropriate dfrA sgRNA into a parental strain containing dCas9 and 
additionally an RFP or GFP marker (two replicates were used, one of each color where 
available, two technical replicates of a single color otherwise --see Table 4.1). Control 
strains contained dCas9 and a fluorescent marker but lacked a guide RNA. 
The growth protocol was similar to that used for pooled growth experiments. Each 
experimental strain and control strains were grown individually to exponential phase, at 
which point each experimental strain was mixed 1:1 with the control strain containing 
the opposite fluorescent marker. Each pair was back-diluted for growth to start the 
experiment and again at the 5-doubling midpoint as in the pooled-growth experiment. 
Formaldehyde-fixed samples taken at the start of the experiment and after 10 doublings 
were counted by flow cytometry to determine the ratio of the experimental to the control 
strain at each timepoint. We computed relative fitness by comparing the ratio at t=0 to 
that after 10 doublings of growth. 
We saw strong agreement between our pooled-growth measurements and the gold-
standard measurements (Figure 4.2). The pooled-growth measurements gave higher 
fitness values overall, which we attribute to differences in experimental conditions (e.g. 
growth in deep-well plates in the individual measurements vs large-volume flasks for the 
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pooled growth experiments). The pooled-growth measurements also had greater noise 
at lower relative fitness, which is an expected consequence of distributing resolution 
(i.e. read depth) over 30,000 strains instead of 2. See Appendix #2 for more discussion 
of this latter issue. 
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Table 4.1 -- fluorophore(s) used, by variant 
 
variant sequence 
flouorophor
e 
AGATCATTGGGCAAATGCCA both 
AGATCATTGGGCTAATGCTA both 
GTCTTTGCCGATAAGCCTGT both 
GTCTTTGCCGATAAGCCTCT both 
AGATCAATGGGCAAATGCCA both 
AGAGCAATGGGCAAATGCCA both 
AGATCATTGGGCATATGCCA both 
AGACCATCGGGCAAATGCCA both 
GGATCATTGGGCAAATGCCA both 
AGATCATTGGGCAAAGGCCA both 
AAATCATTAGGCAAATGCCA gfp 
AGATCATCGGGCAAATGGCA gfp 
AGATCATTGGGCAAATTCCA red 
AGATCATTGGGCAAATGCCC gfp 
GTCTGTGCCGATAAGCCTGT both 
GTGTTTGCCGATAAGCCTGT both 
GTCTTTGCCGACAAGCCTGT both 
GTCTTTGCCGATAAGCTTGT both 
GTCTTGTCCGATAAGCCTGT both 
GTCTTTGCCGATCAGCCTGT both 
GTCTTTGCCGATAAGCATGT red 
GTCTTTGCCTATAAGCCTGT red 
GTCTTTGCCGATAAGCCTGG red 
GTCTTTGCCGATAAGGCTGG red 
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Figure 4.2 
Comparison of relative fitness measurements from pooled growth experiments and 
individual competition experiments for mismatched dfrA guides. 
Fitness of strains with mismatched, variable efficacy sgRNA guides targeting dfrA was 
computed by using deep sequencing at the beginning and end of the experiment to 
determine changes in their fractional representation in a large strain library containing 
mismatched guides against every B. subtilis essential genes at t=0 and t=10 doublings 
(x-axis). Individual strains containing these same sgRNAs against dfrA and a GFP/RFP 
fluorescent marker were grown in competition with a strain with the other fluorescent 
marker but lacking the guide. The fractional representation of each guide strain vs the 
control at 0 and 10 doublings was determined by flow-cytometry. Relative fitness values 
were computed from the change in fractional representation (y-axis). 
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Appendix #2 
Evaluating Success 
Experimental design is critical for extracting maximal information about strain 
phenotypes. We calculate growth rate of each strain relative to the wildtype growth rate 
by using deep sequencing to compare the fractional representation of that strain at the 
start of dcas9 induction (t=0) and after 10 wildtype doublings (t=10). Since there is a 
2^10 = 1000-fold increase in wildtype cells during 10 doublings, cells that do not grow 
will be diluted out and therefore experience a 1000-fold decrease in abundance relative 
to wildtype. To observe a no-growth phenotype therefore requires the ability to detect a 
decrease of this magnitude. The feasibility of achieving this depends on the complexity 
of the library, and the depth of sequencing. 
We can conservatively expect to get 3 x 10^7 sequencing reads per sample. Our main 
pooled-growth experiments each comprise around 3 x 10^4 distinct strains. If our library 
were perfectly uniform at the start of our growth measurement, each guide would have a 
starting read count of 10^3 -- just enough to detect a relative fitness of 0. But no library 
is perfectly uniform in actual practice. Some strains will be heavily over-represented in 
the starting pool, and some will be altogether absent. Therefore, the number of strains is 
not, by itself, adequate to specify library complexity. 
Incorporating this non-uniformity into our reasoning, we therefore introduce a third factor 
directly tied to our desired outcome. We declare a minimum starting count of 100 for our 
strains, below which we cease to consider a strain part of the pool for relative fitness 
calculation in a given sample. This ensures that we will correctly measure relative 
fitness values at least as extreme as 0.35. We can then work backwards from this cutoff 
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to determine an effective library complexity -- i.e. the size of sample needed to capture 
the diversity relevant to our final measurement. 100 reads out of a 3 x 10^7-read depth 
represents a frequency of 1/(3 x 10^5). This tells us that our effective library complexity 
is 3 x 10^5 elements. Any step with fewer than 3 x 10^5 elements therefore represents 
a bottleneck, almost certainly causing loss of diversity even if the step is itself otherwise 
perfectly uniform. (For example, if we collect only 1 x 10^5 transformants during the 
transformation step of library construction, elements representing only 1/(3 x 10^5) will 
likely be lost from the pool entirely.) 
To minimize information loss, we worked to maintain a coverage of strains at 10-fold 
over threshold at every step by ensuring a minimum of 3 x 10^6 events (e.g. 
transformants collected, cells in starting inoculum, ...). There are three ways to think 
about information retention and evaluate our success in this regard. First, is the 
distribution of sub-population frequencies consistent through the process of constructing 
and preparing our library? Second, what fraction of guides are empirically retained 
above the designated cutoff to the start of our experiments? And finally are the resulting 
computations replicable? 
We explored these questions with our guide libraries for B. subtilis. 
To address the first question, we sequenced guides to interrogate numerical diversity at 
three stages: after ligating synthesized oligos into a plasmid library, after transforming 
plasmids carrying genomically integrating sgRNA constructs into a strain library, and 
after recovering strains to exponential phase from frozen aliquots to begin an 
experiment. Comparing the first two (Figure 5.1) or the latter two (Figure 5.2) samples, 
we saw that the representation of most guides did not change. The greater 
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discrepancies seen in 5.1 (vs. 5.2) highlight the importance of understanding -- and 
where possible widening -- bottlenecks. In constructing our library, the most difficult 
place to maintain high numbers of entities/events was in the transition from plasmid 
library to strain library. Transformation and, especially, plating/recovery of individual 
colonies, is extremely resource intensive and difficult to scale. We were able, but just 
barely, to maintain our desired 10-fold coverage through these transitions. 
The second question can be answered by simply observing which guides are above the 
cutoff. Overall, the vast majority of guides (83%) were retained above cutoff to the start 
of our experiment (i.e. to the right of the red-line demarcation in Figure 5.3). More 
importantly, on a per gene basis, we saw retention of a vast majority of guides (median 
of 84/100) with even the worst-case gene close to 50% retention (Figure 5.4). Finally, 
our cutoffs were sufficiently high, and our bottlenecks sufficiently wide, to allow high 
reproducibility in our pooled-growth fitness measurements. This was true for B. subtilis 
(representative replicates compared in Figure 5.5, R = .95) and for E. coli 
(representative replicates compared in Figure 5.6, R=0.96). 
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Figure 5.1 
Information preservation between plasmid library and strain library 
sgRNA guide loci were amplified from B. subtilis plasmid library DNA (x-axis) or 
genomic DNA of frozen B. subtilis strain library stocks (y-axis) and counted via deep 
sequencing. 
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Figure 5.2 
Information preservation between strain library construction and start of growth 
experiment 
sgRNA guide loci were amplified from genomic DNA of frozen B. subtilis strain library 
stock (x-axis) or post-recovery samples at the outset of growth experiment (y-axis) and 
counted via deep sequencing. 
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Figure 5.3 
Overall guide retention above cutoff 
Unnormalized guide counts from sequencing a single t0 sample of B. subtilis guides 
(~65M total reads). Red line highlights cutoff at log2(100). 
 
Figure 5.4 
Per-gene guide retention above cutoff 
Genes binned by number of guides remaining after filtering sub-cutoff guide counts as 
shown in Figure 5.1. 
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Figure 5.5 
B. subtilis replicates 
Representative comparison of fitness measurements for two growth replicates (B. 
subtilis). 
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Figure 5.6 
E. coli replicates 
Representative comparison of fitness measurements for two growth replicates (E. coli). 
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Appendix #3 
Trimethoprim Experiments 
Measuring relative fitness during pooled competitive growth of singly mismatched 
CRISPRi guides can tell us a great deal about the importance of a gene. The meaning 
of this metric is quite clear so long as a strain is both healthy enough to remain entirely 
in the observed pool for the duration of an experiment and unhealthy enough to fall in 
fractional representation in time to distinguish it from the random walk of control 
replicates. Appendix 2 frames the considerations necessary to account for the former 
concern -- capturing extremely low fitness. Here we consider the latter -- guides/strains 
with fitness scores not readily distinguished from background. 
Many guides in our singly mismatched CRISPRi experiments did not impart phenotypes 
outside the variance of the internal controls (strains with non-targeting sgRNAs). The 
guides in question may actually be non-functional, failing to alter transcription of the 
target gene. Alternatively, these guides may decrease expression of the targeted gene 
but not affect fitness either because the gene product in question is normally expressed 
at a slight excess or because the cell has a buffering mechanism to counteract 
downregulation. 
To determine whether these guides actually decrease expression, we took advantage of 
the known synergy between the drug trimethoprim and its direct target DfrA, established 
in Chapter 2. We performed pooled competitive growth experiments on our full library, 
including our large collection of dfrA guides, in the presence of two sub-MIC doses of 
trimethoprim (15 and 30 ng/ml). The higher dose minimally, but detectably, impacts the 
overall growth of our library as measured by overall optical density (Figure 6.1). 
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Because 10 ng/mL was insufficient to perturb overall growth, we selected a slightly 
higher dose of 15 ng/mL for our "low" dosage. Our measurements of the effects of these 
concentrations of trimethoprim on our entire library, excluding those encoding the 
folate pathway, indicate that strain growth was not differentially affected at these 
concentrations of trimethoprim (Figure 6.2). In contrast, strains with dfrA guides (Fig 
6.3) were severely affected, and growth of other genes in the pathway was affected less 
severely (Fig 6.5-6.10). This result strongly suggests that, without drug, the "no-
phenotype" dfrA guides were knocking down gene expression, although they do not 
affect growth. 
Exploring this issue further reveals that for the higher of the two sub-MIC doses (30 
ng/mL trimethoprim), those dfrA strains with reduced growth in the absence of 
trimethoprim were predominantly pushed into a regime of such low fitness that it is 
difficult to distinguish one from another, while those dfrA strains whose growth was 
indistinguishable from the wt cover nearly the full range of dfrA phenotypes in the 
presence of trimethoprim (Figure 6.4). 15ng/ml trimethoprim had similar but less severe 
effects. Guides like these will be useful in other experiments, where we perturb the 
strains with a panel of secondary stressors to uncover phenotypes, and will provide a 
wealth of data about regulation and function of the essential genes. 
Our trimethoprim experiment captures other expected phenotypes for important 
secondary targets in the folate pathway (Figure 6.5-6.10). The one member of the fol 
family in our set which is not essential, folD, shows a slightly different phenotype than 
the others, with the lower dose phenotypes closely resembling those for the no-drug 
case, but showing striking synergy at the higher dose. A small number of genes outside 
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the folate pathway also appear to have slight synergy phenotypes in the presence of 
trimethoprim, such as aroE -- known to be peripherally associated with folate pathway 
(Babitzke, Gollnick, and Yanofsky 1992) (Figure 6.11), sufB and fmt -- two genes 
related to iron metabolism (Figure 6.12, 6.13), and the as yet poorly characterized 
reductase ylbQ (Figure 6.14). These phenotypes were detectable for the parent guides, 
but a consistent shift across a series of knockdowns makes detection of subtle 
phenotypes an easier proposition. We believe these guide series libraries consequently 
stand to make screening for unknown interactions with secondary stressors much more 
sensitive. 
 
Figure 6.1 
Selection of trimethoprim doses for growth experiments. 
B. subtilis library was grown with a range of trimethoprim doses, tracking OD 600. 10 
ng/mL trimethoprim did not substantially impact growth of library, whereas 33 ng/mL did. 
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Figure 6.2 
Effect of trimethoprim dose on B. subtilis essential genes [excluding the folate pathway] 
Competitive pooled-growth experiments were performed on the initial B. subtilis ve-
CRISPRi library in LB + 1% Xylose, with either 0, 15, or 30 ng/mL trimethoprim. 
Average relative fitness values plotted for each strain show the comparison between no-
trimethoprim replicates (x-axis) and 15 ng/mL (blue) or 30 ng/mL (orange) replicates (y-
axis). Most strains are not differentially impacted relative to the control strains. This 
analysis excludes strains with guides targeting folate pathway genes: dfrA, folB, folC, 
folD, folE, folK, sul (c.f. Figures 6.3-6.10). 
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Figure 6.3 
Effect of trimethoprim dose [dfrA] 
Data as described in Figure 6.2 but restricted to guides targeting dfrA 
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Figure 6.4 
Trimethoprim dose exposes phenotypes for dfrA strains 
Alternate representation of data from Figure 6.3. dfrA guides are further sub-filtered to 
those effecting no-drug phenotypes within one standard deviation of control median (left 
violin plot). Distribution of fitness scores for these same strains greatly expands in the 
presence of 15 ng/mL (center violin plot) or 30 ng/mL (right violin plot) trimethoprim. 
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Figure 6.5 
Effect of trimethoprim dose [folB] 
Data as described in Figure 6.2 but restricted to guides targeting folB 
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Figure 6.6 
Effect of trimethoprim dose [folC] 
Data as described in Figure 6.2 but restricted to guides targeting folC 
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Figure 6.7 
Effect of trimethoprim dose [folD] 
Data as described in Figure 6.2 but restricted to guides targeting folD 
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Figure 6.8 
Effect of trimethoprim dose [folE] 
Data as described in Figure 6.2 but restricted to guides targeting folE 
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Figure 6.9 
Effect of trimethoprim dose [folK] 
Data as described in Figure 6.2 but restricted to guides targeting folK 
 136 
 
Figure 6.10 
Effect of trimethoprim dose [sul] 
Data as described in Figure 6.2 but restricted to guides targeting sul 
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Figure 6.11 
Effect of trimethoprim dose [aroE] 
Data as described in Figure 6.2 but restricted to guides targeting aroE 
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Figure 6.12 
Effect of trimethoprim dose [fmt] 
Data as described in Figure 6.2 but restricted to guides targeting fmt 
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Figure 6.13 
Effect of trimethoprim dose [sufB] 
Data as described in Figure 6.2 but restricted to guides targeting sufB 
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Figure 6.14 
Effect of trimethoprim dose [ylbQ] 
Data as described in Figure 6.2 but restricted to guides targeting ylbQ 
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Appendix #4 
Small Libraries 
Our model's robust predictions of knockdown efficacy suggest that we can retrieve the 
most salient features of knockdown/phenotype relationships with a much smaller 
number of guides. To test this idea, we built small-scale libraries comprising ~11 guides 
per essential gene for both B. subtilis and E. coli, and then grew and analyzed these 
libraries as described for the larger libraries. Whereas the B. subtilis library was 
designed from phenotypes measured in an initial larger-scale experiment, the E. coli 
library was designed solely based on the predictive model. 
Phenotypes in the minimal libraries correlate well with the model predictions for E. coli 
(Figure 7.1, R=0.63) and B. subtilis (Figure 7.2, R=0.59) and with measurements from 
overlapping experiments with large pools (Figure 7.3, 7.4). When knockdown 
predictions are considered on a per-gene basis they correspond even more closely with 
median correlations of 0.78 (Figure 7.5) for B. subtilis and 0.58 (Figure 7.6) for E. coli. 
This compares favorably to the relationships exhibited by the large libraries, with 
correlations of 0.70 (Figure 7.7) and 0.41 (Figure 7.8) respectively. Genes in B. subtilis 
generally show good correspondence for both libraries (Figure 7.9). Genes with poor 
correlation for the small E. coli library generally also have low correlations for the large 
library and low-magnitude phenotypes overall, pointing to the non-linearity of the true 
knockdown/phenotype curve of the gene as the primary source of the discrepancy 
(Figure 7.10). 
We successfully obtained intermediate phenotypes for the vast majority of our targeted 
genes. 95% of genes had at least 2 guides with phenotypes in the targeted range of 
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10% to 90% of wildtype growth in subtilis (Figure 7.11), and for the strictly prediction-
based E. coli library this rose to 3 guides (Figure 7.12). Half of genes in the latter library 
had at least 10 (i.e. nearly all) guides in the targeted range. This compares favorably to 
outcomes for the larger libraries (G), and demonstrates that even a small library of 
mismatch guides was sufficient to introduce a meaningful variety of knockdown 
phenotypes for each included gene. 
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Figure 7.1 
B. subtilis small library fitness vs model prediction. 
Fitness measurements for strains in small B. subtilis library. Competitive pooled growth 
experiments were structurally identical to those performed on the large libraries save 
that a smaller physical volume was used for each replicate (15 mL instead of 150 mL). 
Guides with no mismatches were assigned knockdown "predictions" of 1.0 (targeting) or 
0.0 (non-targeting control). 
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Figure 7.2 
E. coli small library fitness vs model prediction. 
Fitness measurements for strains in small E. coli library. Competitive pooled growth 
experiments were performed exactly as decribed for the large libraries save cultures 
were 15 mL rather than 150 mL. Guides with no mismatches were assigned knockdown 
"predictions" of 1.0 (targeting) or 0.0 (non-targeting control). 
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Figure 7.3 
Comparison of B. subtilis fitness scores measured for small library vs. original pre-
screen library 
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Figure 7.4 
Comparison of E. coli fitness scores measured for small library vs. large library 
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Figure 7.5 
B. subtilis small library Pearson correlations by gene 
Pearson R was computed between predicted knockdown and measured fitness for 
guides targeting each gene. Histogram shows distribution of per-gene Pearson R 
scores. 
 
Figure 7.6 
E. coli small library Pearson correlations by gene 
[See Figure 7.5.] 
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Figure 7.7 
B. subtilis large library Pearson correlations by gene 
[See Figure 7.5.] 
 
Figure 7.8 
E. coli large library Pearson correlations by gene 
[See Figure 7.5.] 
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Figure 7.9 
B. subtilis small v. large library comparison of Pearson correlations by gene. 
Individual values as computed for 7.5/7.6, compared. Coloration of dots indicates 
extremity of phenotype; genes with darker colors have more extreme phenotypes. 
Pearson correlations were generally high for all genes in both libraries. 
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Figure 7.10 
E. coli small v. large library comparison of Pearson correlations by gene. 
Individual values as computed for 7.7/7.8, compared. Coloration of dots indicates 
extremity of phenotype; genes with darker colors have more extreme phenotypes. More 
genes show low correlation in E. coli, particularly genes with low-magnitude 
phenotypes. More phenotypes were captured by the small library experiment. 
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Figure 7.11 
Guides in targeted range per gene for B. subtilis (small library) 
Guides with phenotypes in the desired range (between 10% and 90% wildtype growth 
rate) were counted for each gene. Histogram shows distribution of per-gene coverages 
for small B. subtilis library. 
 
Figure 7.12 
Guides in targeted range per gene for E. coli (small library) 
Guides with phenotypes in the desired range (between 10% and 90% wildtype growth 
rate) were counted for each gene. Histogram shows distribution of per-gene coverages 
for small E. coli library. 
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Figure 7.13 
Guides in targeted range per gene for B. subtilis (large library) 
Guides with phenotypes in the desired range (between 10% and 90% wildtype growth 
rate) were counted for each gene. Histogram shows distribution of per-gene coverages 
for large B. subtilis library. 
 
Figure 7.14 
Guides in targeted range per gene for E. coli (large library) 
Guides with phenotypes in the desired range (between 10% and 90% wildtype growth 
rate) were counted for each gene. Histogram shows distribution of per-gene coverages 
for large E. coli library. 
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Appendix #5 
Double-Mismatch Guides 
Our approach of titrating guide efficacy with a single mismatch captures a wide range of 
knockdowns for any gene target. In Appendix #3 we showed evidence that such guides 
can impart even the very low levels of knockdown necessary to capture a range of 
phenotypes in the presence of a synergistic secondary stress. Prior to measuring actual 
outcomes for these guides we were concerned that a single mismatch might be 
insufficient to our aims, and so our initial libraries (including our GFP library) 
incorporated a sizeable number of guides (49 per parent locus) with two mismatched 
bases. These guides did not prove necessary for our primary objectives. They do, 
however, provide a second lens through which to examine the performance of the 
predictive model (trained exclusively on single-mismatch guide outcomes). 
Because the model was not built to consider multiple mismatches, we cannot directly 
apply it to these guides. However, because the model predicts knockdown as a fraction 
of parent knockdown, we can assume independence --i.e. assume that the impact of 
each mismatch is unchanged by the match at other positions in the guide -- and simply 
multiply the fractional predictions together, declaring that a mismatch imparting a 75% 
knockdown and a mismatch imparting an 80% knockdown would together impart a 
(75% * 80%) = 60% knockdown. Certainly the relationship is unlikely to be truly 
independent in practice. Nevertheless, we find the predictions from this conscious over-
application of the single-mismatch model to be surprisingly accurate. 
For our GFP data, predictions of the double-mismatch guides correspond very well to 
measured outcomes across both organisms (Figure 8.1, R = 0.73). Furthermore, when 
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we look at fitness outcomes for our broad libraries of dfrA or murAA guides in B. subtilis 
(for which our initial libraries included double-mismatch guides), we saw a meaningful 
correspondence even though many of the guides present no phenotype across 10 
generations (dfrA: Figure 8.2, R = 0.50; murAA: Figure 8.3, R = 0.56). Furthermore, in 
the presence of trimethoprim (see Appendix #3) we find the prediction/fitness 
correspondence rises even further (15 ng/mL: Figure 8.4, R = 0.60; 30 ng/mL: Figure 
8.5, R = 0.66). 
We do not recommend the application of these double-mismatch guides in practice. 
They were more challenging to predict precisely and, in light of the broad titration 
coverage of single-mismatch variants, unnecessary. These data do however reinforce 
the predictive power of our single-mismatch linear model, and provide further evidence 
that the fundamental mechanism of the CRISPRi system is robust to many particulars of 
context. 
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Figure 8.1 
Predicted vs. Measurement (via FACS-seq) of GFP Knockdown 
Comparison of predicted knockdown to average measured knockdown for GFP library. 
Predictions were made by separately applying single-mismatch model to each 
mismatch in isolation and multiplying the outputs. 
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Figure 8.2 
Predicted Knockdown vs Measured Relative Fitness (Bsu/dfrA) 
Comparison of predicted knockdown to measured relative fitness for dfrA library in B. 
subtilis. Predictions were made by separately applying single-mismatch model to each 
mismatch in isolation and multiplying the outputs. 
 157 
 
Figure 8.3 
Predicted Knockdown vs Measured Relative Fitness (Bsu/murAA) 
Comparison of predicted knockdown to measured relative fitness for murAA library in B. 
subtilis. Predictions were made by separately applying single-mismatch model to each 
mismatch in isolation and multiplying the outputs. 
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Figure 8.4 
KD Prediction vs. Fitness (Bsu/dfrA) [15 ng/mL trimethoprim] 
Data as for Figure 8.2, but using fitness measurements from samples with 15 ng/mL 
trimethoprim. 
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Figure 8.5 
KD Prediction vs. Fitness (Bsu/dfrA) [30 ng/mL trimethoprim] 
Data as for Figure 8.2, but using fitness measurements from samples with 30 ng/mL 
trimethoprim. 
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Appendix #6 
sgRNA Design 
Before any of the libraries described in this work could be created or used, we needed 
to design guides to target particular genomic loci. When we began our project, there 
were no broadly available tools for this purpose, and so I created scripts to process 
available information about a genome and identify the dCas9 targets available for each 
gene therein. 
In hopes of enabling other researchers to perform this task for their bacterium, I have 
made this code available as a public-facing github repository at 
https://www.github.com/traeki/sgrna_design 
The code used a clever idea originally conceived by Max Horlbeck to ascribe a 
Specificity score to each guide. In essence, we used the bowtie alignment tool to find 
alternate off-target matches for each designed guide. The bowtie tool uses the per-base 
"phred score" provided by Illumina sequencers to soften its search stringency lest mis-
called nucleotides prevent alignments. By treating the list of available PAM-adjacent 
guide candidates as "reads" and providing a "phred-score" that loosely captures the 
"targeting importance" of each position in the 20-nucleotide guide, we can induce bowtie 
to give back off-target match candidates. By setting our tolerance threshold to be 
progressively more permissive in iterative sweeps, we can identify the candidate guides 
that become "non-specific" within each band of tolerance, and score the recorded 
targets accordingly. 
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Guides were then saved to a file annotated with information about their position, both in 
absolute terms, and in relation to any coding features (i.e. genes) recorded in the 
provided genome. Users can then subselect guides for specific genes according to their 
preferences and needs. 
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Appendix #7 
Mismatch Guide Design 
Working with mismatch-CRISPRi adds an obvious layer of complication to the process 
of designing guide libraries. Furthermore, pooled-growth competition libraries require 
additional layers of analysis to understand. I created scripts allowing us to model and 
predict knockdowns for mismatch-CRISPRi guides, choose guides for mismatch-
CRISPRi libraries based on our predictive model, and interpret and analyze the 
sequencing output from pooled-growth experiments using those libraries. 
I have made the code, along with our predictive model, available at 
https://www.github.com/traeki/mismatch_crispri. I hope this will serve not only to 
document our work, but also to facilitate adoption of these ideas and techniques in other 
labs. 
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Conclusions / Future Directions 
The work described in the preceding chapters develops and demonstrates tools for 
systematically compromising and interrogating the function of essential genes in 
bacteria. Where previous efforts to explore the function of these genes required 
significant investment of time and effort just to investigate a single gene in vitro, we can 
now construct and study strain libraries spanning the entire essentialome of an 
organism. In chapter 2, we explored a variety of assays afforded by such libraries. In 
chapter 3 we showed that these techniques remain effective in extremely divergent 
bacterial models. These methods and assays, along with the software tools we provide 
to simplify their adoption, will permit the rapid interrogation of gene function across the 
entire genomes of many -- if not most -- bacteria of interest. This work can be carried 
forward in many directions, several of which present themselves as immediately 
accessible and interesting. 
First and most straightforward is the unification of Chapters 2 & 3. In Chapter 2, we 
explored the power of secondary environmental stressors such as chemicals or nutrient 
deficiencies to expose phenotypes otherwise buffered in strains with very low (i.e. 
uninduced) essential knockdowns. In Chapter 3, we used systematically compromised 
mismatch libraries to quantify the expression breakpoint beneath which each essential 
gene first begins to significantly impair growth, and how rapidly growth deteriorates as 
expression is constrained even further. By performing analogous pooled-growth assays 
in the context of secondary environmental stressors, we can combine these insights. 
Not only will this allow us to further refine our genetic network, it will in many cases 
allow us to flesh out deeper questions about their relationships. In Chapter 3 and 
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Appendix 3 we discuss a small proof-of-concept using trimethoprim. Pooled-growth 
assays under very low doses of trimethoprim reveal the expected outcome that dfrA and 
other genes involved in folate metabolism are much more impaired at much lower levels 
of knockdown than other knockdowns. Our comparisons of outcomes with and without 
trimethoprim demonstrate that mismatched sgRNAs can induce expression phenotypes 
even milder than those achieved by the uninduced system (with perfectly matched 
sgRNAs) in Chapter 2. By using these more sensitive strains for our measurements of 
stress interactions, we will be able to make much more refined estimates of the precise 
degree to which cells are buffering/shielding against specific problems. The 
trimethoprim assays also demonstrate that the rate of impairment depends both on drug 
concentration and on degree of knockdown, and most importantly that this interaction 
differs by gene. We can use these differences to infer not just the similarity or 
interaction between two genes, but indeed to make and test hypotheses about the 
quantitative and directional nature of those interactions. Furthermore, as we have 
already constructed small versions of these libraries (discussed at length in Appendix 
4), the necessary growth assays will have much a smaller footprint, and require little to 
no new effort beyond the execution of the assays themselves. 
Another exciting opportunity afforded by this work is epistasis interrogation with double-
knockdown strains. Though they code for a specific genetic target, sgRNAs act in trans 
relative to their own genomic location, and also are quite short compared to the genes 
they are. This allows installation of two sgRNAs to a single small locus, from which they 
can subsequently be amplified and sequenced (e.g. with paired-end techniques), 
identifying two-sgRNAsknockdown strains within a pooled growth context and permitting 
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experiments analogous to those performed in Chapter 3 using single sgRNA libraries. 
We scratched the surface of this possibility in Chapter 2, using multiple-knockdown 
strains to explore redundancies among the PBP family of genes. Working with perfectly 
matched sgRNAs, however, it is not possible to meaningfully measure knockdown pairs 
comprising both an essential and a non-essential gene. With induction sufficient to 
produce a phenotype for a non-essential gene, the phenotype of the essential gene 
(death) dominates the measurement. What's more, even if two essential genes are 
examined in the absence of induction -- or two non-essential genes, under full induction 
-- the actual situational importance of those genes is not binary. Essentiality is a 
quantitative trait, including "non"-essentiality! Such pairs might work to elucidate some 
epistatic interactions, in some contexts, but it would be very difficult to control for the 
possibility that one phenotype would simply overshadow the other. The possible domain 
of epistasis maps constructed with fully-matched sgRNAs is therefore importantly 
constrained. Furthermore, essential genes are the connection hubs of genetic networks, 
and their absence from any effort to explore genetic interactions dramatically diminishes 
the scope and granularity of inquiry. Mismatch-CRISPRi allows separately tuned 
modulation of multiple targets in a single cell. sgRNAs can be drawn from pre-measured 
sets (indeed for libraries in E. coli or B. subtilis they can be drawn directly from those 
presented in this work), or multiple sgRNAs can be used for each gene. The latter 
approach of course has significant scale implications, and pairs best with a curated 
subset of genes. Such a library would produce many measurements for each gene pair. 
This obviates the need for pre-screening to determine optimal knockdowns, but it also 
increases the robustness of detection for any but the most fine-grained distinctions. 
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Negative control sgRNAs of course can (and should) be included in each "axis" of such 
a two-dimensional knockdown library, both to provide control-control pairs for 
determination of "wildtype" phenotype and to provide statistically robust measurements 
of the phenotype for each individual sgRNA in isolation, internal to the experimental 
context. Using multiple guides per essential gene, where feasible, will afford similar 
statistical refinement to the measured fitness of paired experimental knockdowns. 
Double-sgRNA libraries will allow us to even more directly associate pairs of genes, and 
can even be assayed using competitive pooled growth in the context of another (now, 
"tertiary") stress condition -- drug, starvation, or otherwise. 
Third, all of these techniques can be applied in organisms other than these two specific 
models. Mismatch-CRISPRi requires the ability to transform both a Cas effector and an 
sgRNA into a background strain. In some organisms (Mycobacteria smegmatis, for 
example), dCas9 does not seem to work effectively, and alternate Cas systems, or 
other tuning, might be required. We nonetheless expect that this system will be 
extremely effective in a great many bacterial hosts, given the evolutionary dissimilarity 
already spanned by the two discussed in this document. The software tools we have 
provided require only basic access to some publicly available software (primarily a 
python installation and access to the bowtie aligner) and a genbank file for the target 
organism, and can then provide as comprehensive a library as needed for partnership 
with S. pyogenes dCas9. (For other Cas systems, the scripts will need to be updated to 
allow for particulars such as rules governing PAM regions.) Researchers are free to 
design arbitrarily scaled libraries of sgRNAs, adjusting the genes covered and number 
of guides included to accommodate their needs and constraints. Tthese libraries must 
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be ordered, cloned, and transformed into background, and that could be more difficult in 
some species than in others. But once the library is installed, the actual competitive 
growth assays should be extremely similar to those describe in Chapter 3, and we think 
this will dramatically speed forays into functional genomics of organisms where such 
exploration was previously prohibitively difficult and slow. 
While these are certainly not the only applications of mismatch-CRISPRi, we anticipate 
that they will be more than sufficient to generate an explosion of insights and 
hypotheses. And while we think such future directions demonstrate the exciting power 
of the techniques explored in this work, it is our sincere hope that these tools will also 
be of even more immediate use for comparitively quotidian applications. Researchers 
already focused on a single gene can separately construct libraries, whether 10 
sgRNAs, 100 sgRNAs, or a comprehensive library like those used for dihydrofolate 
reductase or GFP, which they can in turn apply to focused exploration of narrowly 
targeted questions and hypotheses. In the timeless words of Emerson, "To know even 
one life has breathed easier because you lived -- this is to have succeeded." We can 
think of few outcomes more satisfying than having simplified, accelerated, or eased the 
work of our brilliant peers, even if only a little. 
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